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  xABSTRACT 
The purpose of this research was to determine the influence of dietary Se on glutathione 
peroxidase (GPx)-1 and 3 activities and relative liver GPx mRNA levels in growing Holstein bull 
calves. Calves (n = 14) were started 28 d after birth on either a Se adequate (0.15 ppm Se) or 
deficient (0.01 ppm Se) diet consisting of 3 growth phases and maintained on the diet until 180 d 
of age. Blood samples were taken from each calf for determination of GPx-1 and GPx-3 activity. 
Three calves were euthanized at d 21 of age for determination of baseline liver GPx-1 mRNA 
level. Four calves from each treatment were euthanized at d 180 of age for determination of liver 
GPx-1 relative mRNA level. Feed intake and average daily gain were not affected by Se level. 
Mean liver Se concentration was higher (P < 0.05) for baseline calves and those fed the Se 
adequate diet than for calves fed the Se-deficient diet, but there was no difference between 
baseline calves and Se adequate calves with respect to liver Se concentration. The GPx-1 activity 
was greater for Se adequate than Se-deficient calves (P < 0.01) but not until d 84 of age. The 
GPx-3 activity was considerably more variable than that of GPx-1 with respect to the trend 
observed for activity by day, and the GPx-3 activity of the Se-deficient group was only less than 
that of the Se adequate group (P < 0.05) on d 180. N-fold differences were calculated for relative 
GPx-1 mRNA levels between treatments. There was a 50% decrease in GPx-1 mRNA for Se-
deficient calves (P < 0.05) compared with the Se adequate calves. Regression analysis also was 
performed to determine the relationship between the various response variables. There was only 
a moderate relationship (r
2 = 0.58) between GPx-1 mRNA transcript levels and GPx-1 activity at 
d 180, despite a correlation coefficient of 0.76. The relationship between GPx-1 mRNA 
transcript level and GPx-3 activity at d 180 was much stronger (r
2 = 0.81), with a correlation 
coefficient of 0.90, which was unexpected, as GPx-3 is generally considered a short-term 
  xi  xii
indicator of Se status and therefore a much more variable response. Erythrocyte GPx-1 activity 
was much more sensitive to Se in the diet and thus reflected the diet more closely than did GPx-
3. However, GPx-3 activity was more highly correlated to GPx-1 transcript levels. These 
unexpected results suggest that another trial utilizing larger sample sizes and serial sampling of 
liver tissue with the sampling of plasma and erythrocytes may provide a clearer picture of the 
relationship between liver GPx-1 mRNA , tissue Se concentration, and GPx enzyme activities in 
neonatal and growing Holstein calves.CHAPTER I 
INTRODUCTION 
Selenium (Se) status is an important indicator of oxidative status and therefore health and 
disease susceptibility. According to Arthur et al. (2003), “Selenium is essential for the efficient 
and effective operation of many aspects of the immune system in both animals and humans.” 
There is increasing evidence concerning nutritional status and immune response in mammals. 
Although numerous micronutrients, including Fe, Cu, Zn, and Se, have received considerable 
attention within the last decade (Failla, 2003), it is research regarding Se and immunity that has 
shown promise to impact health. One of the most surprising findings is that Se deficiency in 
mice promotes viral mutation and the subsequent development of virulent strains, as 
demonstrated by the infection of Se-deficient mice with a normally benign virus, Coxsackie virus 
B3. When Se-deficient mice were infected with Coxsackie virus, there was a significant increase 
in mortality, while Se-adequate infected mice showed little to no signs of disease, thus indicating 
an increase in infectivity and virulence as a result of potential genomic mutation in the 
previously avirulent virus when replicated within a Se-deficient host (Beck et al., 1994a; Beck et 
al., 1994b; Beck et al., 1994c). The connection between Se status and viral mutagenesis 
primarily involves oxidative stress (Beck and Levander, 2000) and the role of selenium as an 
antioxidant is mediated through the Se-dependant glutathione peroxidases (GPx; EC 1.11.1.9) 
(Rotruck et al., 1973). These are potent antioxidant enzymes responsible for catalysis of the 
reaction in which reactive oxygen species (ROS) such as hydrogen peroxide are converted to 
water (Flohe, 1973). Oxidative stress, which results from a build-up of ROS, has been found to 
have a considerable effect on the evolution of viruses from avirulent strains to virulent strains in 
vivo, an effect that is thought to be due largely to genomic damage incurred by the virus as it is 
  1exposed to a highly oxidative environment (Beck and Levander, 2000). In addition, Se 
deficiency has been known to have other detrimental effects on the immune system and may also 
encourage the development of many pro-inflammatory compounds responsible for the 
predisposition to diseases such as heart disease and cancer (Arthur et al., 2003). Selenium 
deficiency is also directly linked with the development of white muscle disease and general 
unthriftiness in cattle and other livestock species (Jenkins and Hidiroglu, 1986).  
  The potential for Se deficiency to have far reaching negative effects is considerable. An 
example of this capacity lies with the negative repercussions of oxidative stress in calves, a 
potentially serious problem within the livestock industry. One of the greatest health impacts of 
calves during weaning, shipping, and the subsequent feedlot adjustment period is Bovine 
Respiratory Disease (BRD), a disease comprised of numerous viral, bacteriological, and 
mycoplasmal components (Ellis, 2001). Bovine Respiratory Disease is the most common and 
economically detrimental affliction to the beef cattle industry (Snowder et al., 2006) and the 
disease complex accounts for the majority of feedlot mortality (Loneragan et al., 2001). We 
hypothesize that selenium deficiency-induced oxidative stress may potentiate not only an 
increase in the incidence of BRD in unhealthy animals, but also in animals that were previously 
in good health. Vaccination at weaning with a modified live virus is the most common method 
for preventing BRD (Snowder et al., 2006) but often little or no concern is given to the selenium 
status or antioxidative status of these animals at the time of vaccination. Research has shown that 
protective effects of live-attenuated vaccine often depend on a number of factors, including host 
nutritional status (Broome et al., 2004), thus the efficacy of such administered vaccines may be 
in question.  Furthermore, in vivo studies involving mice (Nelson et al., 2001) have shown that 
virus replicated in Se-deficient mice results in increased morbidity and mortality when then used 
  2to infect healthy, Se-adequate mice. This has been hypothesized to have serious implications 
when the co-mingling and transport of calves of unknown health and oxidative status is taken 
into consideration. 
Despite the mounting evidence linking Se deficiency to disease and disease susceptibility, 
little research is available concerning the Glutathione Peroxidase activity-based categorization of 
selenium status and deficiency in the postnatal and growing calf. Research has been conducted 
concerning the effect of Se deficiency in young animals when exposed to agents such as Bovine 
Rhinotracheitis Virus (Reffett et al., 1988) and Brucellosis vaccine in cattle (Nemec et al., 1990); 
however, these studies did not attempt to categorize the extent to which these animals were made 
selenium deficient. Furthermore, little information is available regarding the connection between 
erythrocyte, plasma, and tissue GPx activity and liver GPx mRNA quantity in selenium deficient 
versus selenium adequate calves.  
  The goal of this research is to provide GPx-based categorization of selenium deficiency 
in postnatal calves to calves at approximately 180 days of age. The hope is that, by providing 
guidelines for determining the extent of selenium deficiency based on common markers of 
selenium status, future researchers may continue to further uncover the link between selenium 
deficiency and disease.  
 
 
 
 
 
 
  3CHAPTER II 
LITERATURE REVIEW 
Selenium in Mammals 
Selenium is considered to be an essential mineral for humans and livestock (Schwarz and 
Foltz, 1957), its role being primarily in the active site of a number of catalytic enzymes including 
thioredoxin reductase and the Se-dependant family of glutathione peroxidases. In humans Se 
deficiency is intimately connected to Keshan disease, which results in cardiomyopathy in 
affected individuals. Before discovery of the connection of Se deficiency to the disease, Keshan 
disease was endemic in regions of the People’s Republic of China known to be deficient in Se 
(Gu, 1983; Yang et al., 1988). Selenium deficiency in domestic livestock is expressed primarily 
as white muscle disease, a debilitating affliction resulting in degeneration and necrosis of both 
skeletal and cardiac muscle that affects young animals (Underwood, 1981). The resulting lesions 
occur primarily as a result of oxidative damage to muscle tissue incurred when GPx activity is 
limited (Gerloff, 1992). In addition, affected animals may exhibit signs of general malaise such 
as weight loss that may be accompanied by diarrhea (Underwood, 1981), anemia (Morris, et al., 
1984), and a decrease in calf weaning weights (Spears et al., 1986). Selenium also has been 
reported to have implications on reproductive health, as there is considerable documentation 
regarding the increase of retained placenta incidence in Se-deficient dairy cattle (Harrison and 
Conrad, 1984; Harrison et al., 1984). Furthermore, abortions, early embryonic death, and 
infertility are all reproductive complications that have been attributed to Se deficiency (Maas, 
1983). Selenium also plays an integral role in the immune system and has been associated with 
increased intracellular kill of S. aureus and E. coli by bovine neutrophils (Gyang et al., 1984; 
Grasso et al., 1990). In cows supplemented with 0.3 ppm Se, intracellular kill of E. coli and S. 
  4aureus was increased in neutrophils, compared with cows that were not supplemented with Se 
(Hogan et al., 1990). Some studies have even suggested the involvement of Se in both murine 
(Arthur et al., 2003) and ruminant antibody production and lymphocyte function (Larsen et al., 
1988; Reffett et al., 1988). The subclinical effects observed in ruminants involving lymphocyte 
function and antibody production have been suggested to be mediated via the activity of GPx 
and, according to Baboir (1984), polymorphonuclear leukocytes are highly sensitive to oxidative 
damage, due primarily to their use of “oxidative bursts” in intracellular killing. 
Selenium absorption occurs primarily in the duodenum with very little absorption by the 
rumen or abomasum (Wright and Bell, 1966). From the duodenum, Se is carried in the blood to 
the liver either via carrier proteins or in the free form, where it is then incorporated into 
selenoproteins, the translation of which is determined genetically (Surai, 2006). While urinary 
excretion is the primary mode of Se regulation in most non-ruminants, the primary site for 
excretion of orally administered Se in the ruminant is via the feces. However, when Se is 
administered either subcutaneously or intravenously, urinary excretion tends to increase versus 
fecal excretion. In addition, it has been shown that lambs maintained on milk have higher urinary 
excretion of orally administered Se before rumen development, but that fecal excretion increases 
as rumen development progresses (Miller and Ramsey, 1988). 
 The Se requirement for beef cattle is 0.1 ppm, with a maximum tolerable intake of 2.00 
ppm (NRC, 2001). Toxicity may occur when extremely high levels of Se are consumed or when 
moderately high levels are consumed over an extended period of time. Acute Se toxicity 
primarily occurs most often with the ingestion of plants that have a high affinity for and tend to 
accumulate Se, but may occur when animals are over-supplemented with Se. When large 
amounts of these seleniferous plants are consumed, acute toxicity symptoms are usually severe 
  5and include a stifled gait, drooped ears, and lowered head. In addition, animals may exhibit high 
body temperature, diarrhea, elevated but weak pulse, and labored respiration. If left untreated, 
acute toxicity may lead to death (Miller and Ramsey, 1988). Chronic toxicity, or alkali disease, 
can occur when livestock graze cereals, grasses, or hays containing 5 to 50 ppm Se for an 
extended period of time. Symptoms generally consist of hair loss and sloughing of the hooves. 
The condition is also characterized by anemia, reduced fertility, stiffness of the joints, and 
painful hoof lesions (Miller and Ramsey, 1988). While Se toxicity is a concern, Se deficiency is 
also an important consideration, as previously discussed. Morris et al. (1984), Hidiroglu et al. 
(1985), and Spears et al. (1986) have reported either clinical or subclinical Se-deficiency in cattle 
grazing forages containing 0.02 or 0.05 mg/kg Se, although there are reports of calves 
consuming semi-purified diets containing only approximately 0.02 ppm selenium with no 
observed clinical signs of deficiency (Reffett et al. 1988; Boyne and Arthur, 1981).  
Determining Se Status 
  Since the discovery by Schwarz and Foltz (1957) that Se was an essential dietary trace 
element, researchers have been looking for the most accurate and precise method of determining 
Se status, both in humans and animals. Numerous methods of determining Se status are 
commonly utilized by laboratories, including determination of serum or plasma Se, whole blood 
Se, liver and other tissue Se, and erythrocyte and plasma glutathione peroxidase activity (Gerloff, 
1992). However, it is these various approaches to assessing Se status that contribute to some 
confusion in the scientific community concerning exactly what adequate Se status entails. In 
addition, reports from various labs tend to deviate considerably (Ullrey, 1987), making the task 
of comparing results between labs difficult. Furthermore, it is somewhat difficult to find research 
correlating specific experimental results such as tissue, plasma, or whole blood Se concentration 
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result, most reports contain data from multiple indicators of Se status and there has been recent 
focus on correlating such indicators to one another. 
Se Concentration in Tissues  
One of the most commonly considered assessments of Se status involves concentration of 
the trace mineral in the body tissues. Tissue Se concentration can be expected to vary with the 
amount and chemical form of Se in the diet, and in most cases rise with increased Se intake, but 
not all tissues accrue Se equally (Ullrey, 1987). A study performed by Behne and Wolters (1983) 
in which rats were fed a commercial diet containing 0.3 ppm Se reported that Se concentrations 
in tissue, on a wet basis, ranked from highest concentration to lowest in the order of kidney, 
liver, testes, adrenals, erythrocytes, spleen, pancreas, plasma, lungs, heart, thymus, skeletal 
muscle, and brain. Studies in cattle of various ages have found that tissue Se concentration 
declines in order of kidney to liver, heart, and skeletal muscle (Maag and Glen, 1967; Kincaid et 
al., 1977; Ullrey et al., 1977; Ammerman et al., 1980). In the study reported by Behne and 
Wolters (1983), Se concentrations in the liver, kidney, erythrocytes, and plasma of rats was 1.29, 
1.45, 0.52, and 0.42 ppm Se, respectively (Table 2.1). Assessment of Se status has been 
performed extensively in various species, including the rat, pig, sheep, chicken, and cow. 
Whanger and Butler (1988) conducted a trial with male weanling Sprague-Dawley rats in which 
they fed the rats increasing levels of Se supplemented to a basal diet containing 0.02 ppm. The 
diets were formulated to contain 0.2, 1.0, 2.0, or 4.0 ppm Se. The researchers found that the rats 
consuming the basal diet had whole blood, liver, and kidney Se concentrations of 0.03 ± 0.01, 
0.02 ± 0.00, and 0.22 ± 0.08 µg Se/g tissue (wet weight), respectively. Rats consuming diets 
supplemented with 0.2 ppm Se as sodium selenite had whole blood, liver, and kidney Se 
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Rats consuming diets supplemented with 1.0 ppm Se as sodium selenite had whole blood, liver, 
and kidney Se concentrations of 0.60 ± 0.04, 0.90 ± 0.10, and 1.53 ± 0.13 µg Se/g (wet weight), 
respectively (Table 2.1). A study was performed by Weiss et al. (1996) in which female rats 
were fed either a basal diet containing 0.007 ppm Se or a diet supplemented with 0.02, 0.05, 0.1, 
0.15, 0.2, or 0.3 ppm Se. The researchers reported that supplementation with 0.02 ppm Se did not 
significantly increase the liver Se concentration above those rats fed the basal diet and that the 
liver Se concentration of rats fed the Se-deficient basal diet was 4% the concentration in rats fed 
the 0.1 ppm diet, on average. Furthermore, liver Se concentration increased sigmoidally with 
increasing dietary Se.  
Swine studies have shown a similar trend regarding Se concentration in body tissues. A 
study performed by Mahan et al. (1999) was conducted to examine the effect of dietary Se level 
and source, either organic Se as SeMet or inorganic Se fed as sodium selenite, on tissue Se and 
various other response variables of grower-finisher pigs. The pigs were bled at trial onset and 
then at intervals of 30, 60, and 90-d after trial initiation. In the study, the researchers found that 
swine fed the basal diet containing an average of 0.06 ppm Se had serum Se concentrations of 
0.080 ppm at d 0 and then of 0.053, 0.057, and 0.063 on d 30, 60, and 90 of the trial, 
respectively. Groups of pigs were also supplemented with 0.05, 0.10, 0.20, or 0.30 ppm Se as 
sodium selenite in addition to the basal diet. No d 0 serum sample was taken for these pigs, but 
pigs were sampled for serum Se on d 30, 60, and 90 of the trial. On d 30 of the trial, serum Se 
concentrations for the pigs fed a diet supplemented with 0.05, 0.10, 0.20, or 0.30 ppm Se were 
0.098, 0.128, 0.121, and 0.137, respectively. Serum Se concentrations for the same pigs on d 90 
of the trial were 0.120, 0.133, 0.139, and 0.152, respectively. When researchers examined liver 
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Author Year 
[Se] in 
Diet 
(ppm) 
[Se] in Liver
[Se] in 
Kidney 
(ppm)
[Se] in RBC  [Se] in 
Plasma
Behne and 
Wolters  1983       0.3    1.29  1.45     0.52  0.42
Whanger 
and Butler  1988  Basal 
(0.02)  0.02 ± 0.00  0.22 ± 0.08 0.03±0.01
a  -
Whanger 
and Butler  1988       0.2  0.72 ± 0.05  1.07 ± 0.06 0.50 ± 0.06
a  -
Whanger 
and Butler  1988       1.0  0.9 ± 0.10  1.53 ± 0.13 0.60 ± 0.04
a  -
a Whole blood. 
from a subset of these groups at 55 kg body weight they reported liver Se concentrations of 
0.195, 0.425, 0.464, 0.526, and 0.522 ppm for pigs fed either the basal diet or a diet 
supplemented with 0.05, 0.10, 0.20, or 0.30 ppm Se, respectively. Pigs at 55 kg of body weight 
were also examined for kidney Se concentrations. When fed either the basal diet containing no 
added Se or the diets containing 0.05, 0.10, or 0.30 ppm Se, the kidney Se concentrations were 
1.305, 1.716, 1.771, and 1.655 ppm Se, respectively. A subset of pigs weighing 105 kg was also 
killed in order to determine both liver and kidney Se concentration. Pigs fed either the basal diet 
containing no added Se or the basal diet containing 0.05, 0.10, or 0.30 ppm supplemental Se had 
liver Se concentrations of 0.258, 0.452, 0.436, and 0.534 ppm Se, respectively. The kidney Se 
concentrations of the same pigs were 1.811, 2.283, 2.333, 2.328, and 2.376 ppm Se, respectively 
(Table 2.2). A study performed by Lei et al. (1998) found that plasma Se concentrations for pigs 
fed a basal diet containing 0.03 ppm Se were 1.25 at d 0 of the trial and 0.18 ppm Se at d 35. 
Plasma Se concentrations increased in pigs with increasing level of Se supplementation, either 
the basal and 0.1 ppm Se, or the basal with 0.3 ppm Se added. The plasma Se concentration at d 
35 in pigs fed the basal diet supplemented with 0.1 or 0.3 ppm Se were 0.84 and 1.62 ppm Se, 
respectively. The second experiment reported in the study found that pigs fed a basal diet 
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respectively, while the same pigs at d 35 had plasma Se concentrations of 0.46, 0.49, and 0.58 
ppm Se, respectively. The results of both Lei et al. (1998) and Mahan et al. (1999) supported 
earlier findings by Groce (1973) and Lowry (1985a, b) (Table 2.2). 
Table 2.2. Se Concentrations [Se] in Various Tissues of Pigs.  
Author Year/Exp  Weight/ 
Age 
[Se] in 
Diet (ppm)
[Se] in 
Liver 
(ppm) 
[Se] in 
Kidney 
(ppm) 
[Se] in 
Plasma 
(ppm)
Groce et al.  1971  25 wk  0.15  0.57  2.06  -
Lowry et 
al.  1985a 8  wk  0.35  0.49  1.36  -
Lowry et 
al.  1985b 8  wk  0.35  0.50  1.42  -
Lei et al.  1998, Exp 
1  9 wk  Basal 
(0.03)  - -  0.18
a
Lei et al.  1998, Exp 
1  9 wk  Basal +  
0.1  - -  0.84
a
Lei et al.  1998, Exp 
1  9wk  Basal +  
0.3  - -  1.62
a
Mahan et 
al.  1999 55  kg Basal 
(0.06)  0.195 1.305  -
Mahan et 
al.  1999 55  kg  Basal + 
0.05  0.425 1.716  -
Mahan et 
al.  1999 55  kg  Basal + 
0.10  0.464 1.771  -
Mahan et 
al.  1999 55  kg  Basal + 
0.30  0.522 1.655  -
Mahan et 
al.  1999 105  kg Basal 
(0.06)  0.258 1.811  -
Mahan et 
al.  1999 105  kg  Basal + 
0.05  0.452 2.283  -
Mahan et 
al.  1999 105  kg  Basal + 
0.10  0.436 2.333  -
Mahan et 
al.  1999 105  kg  Basal + 
0.30  0.534 2.376  -
a sampled on d 35 of trial. 
Numerous studies have also been performed to assess the effect of Se supplementation on 
tissue Se concentration in cattle. Maag and Glen (1967) reported that 12 month old steers 
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1.08 to 1.32 ppm and 1.13 to 1.20 ppm, respectively (Table 2.3). Kincaid et al. (1977) found that 
one month old calves consuming 0.3 ppm Se in an unsupplemented diet had kidney and liver Se 
concentrations of 2.70 and 0.91 ppm, respectively. In addition, a study performed by Ullrey et al. 
(1977) in which 15 to 18 month old steers were fed a diet containing approximately 0.18 ppm Se 
found the animals to have kidney and liver Se concentrations of 1.37 and 0.38, respectively 
(Table 2.3). A study was also performed by Awadeh et al. (1998) in which growing Holstein 
heifers were fed either 0.41 or 0.73 ppm Se from 92 ± 7 d of age until approximately 180 d of 
age. Heifers fed the adequate diet (0.41 ppm Se) had a mean serum Se concentration of 0.115 
ppm. Calves fed the excessive diet (0.73 ppm Se) had a serum Se concentration of 0.287 ppm. 
The same group performed another study in which pregnant, adult crossbred beef cows were fed 
one of three experimental mineral premixes designed to contain 20, 60, or 120 ppm Se as sodium 
selenite. The estimated intakes of the three mineral salts were 2.4, 4.7, and 8.7 mg Se/d, 
respectively. Cows consuming the mineral salt containing 20 ppm Se were found to have a whole 
blood Se concentration of 0.110 ppm. The same cows were found to have an average serum Se 
concentration of 0.491 ppm, indicating that over 50% of the Se in the whole blood of those cows 
was contained in the cellular fraction, most likely in the erythrocytes. Cows consuming mineral 
premixes containing 60 or 90 ppm had whole blood Se concentrations of 0.154 and 0.192 ppm, 
respectively, and serum Se concentrations of 0.86 and 0.81 ppm, respectively. Rowntree et al. 
(2004) reported average plasma selenium concentrations for selenium-drenched pregnant, adult 
cows that ranged between 0.970 ppm and 0.619 ppm, depending on the time of year. In this 
study, cows sampled in May had the highest plasma selenium concentrations and when sampled 
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0.30 ppm less than when sampled in May (2004) (Table 2.3). 
Table 2.3. Se Concentrations [Se] in Various Tissues of Cattle. 
Author Year  Age  [Se]  in 
Diet, ppm 
[Se] in 
Liver, 
ppm 
[Se] in 
Kidney, 
ppm 
[Se] in 
Plasma, 
ppm
Maag and 
Glen 
1967 12  mo  old 
steers 
0.11      1.13 to 
1.20 
    1.08 to 
1.32  -
Kincaid et 
al. 
1977 1  mo  old 
calves 
0.30 0.91 2.70  -
Ullrey et 
al. 
1977  15 – 18 mo 
old steers 
0.18 0.38 1.37  -
Awadeh et 
al. 
1998  ~ 180 d old 
heifers 
0.41 -  -  0.115
a
Awadeh et 
al. 
1998  ~ 180 d old 
heifers 
0.73 -  -  0.287
a
Awadeh et 
al. 
1998 Pregnant, 
adult cows
b
      20
c -  -  0.049
a
Awadeh et 
al. 
1998 Pregnant, 
adult cows
b
      60
d -  -  0.154
a
Rowntree 
et al. 
2004 Pregnant, 
adult cows 
    20 mg,   
daily 
-  -         0.061 
to 0.097
Rowntree 
et al. 
2004 Neonatal 
heifers
e 
1 mg
f -  -  0.072
Rowntree 
et al. 
2004 Neonatal 
heifers
g 
1 mg
f -  -  0.119
Rowntree 
et al. 
2004 Neonatal 
heifers
h 
1 mg
f -  -  0.089
 
a Concentration of Se in serum. 
 
b 90 d prepartum to 3 mos postpartum. 
 c Concentration of Se in a supplemental salt. Estimated daily intake per cow was 2.4 mg/d. 
 d Concentration of Se in a supplemental salt. Estimated daily intake per cow was 4.7 mg/d. 
e d 0 of age. 
f one-time injection, immediately after birth. 
g d 1 of age. 
h d 6 of age. 
 
Often of interest is the effect of cow Se status on Se concentrations in the tissues of 
neonatal and growing calves, because it has been shown that Se effectively passes through the 
placental barrier in cattle (Van Saun et al., 1989). Early signs of Se-deficiency as well as other 
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case of Se, white muscle disease or neonatal ataxia (Abdelrahman and Kincaid, 1993). 
Therefore, tissue reserves of such nutrients in the fetal and neonatal calf are of considerable 
interest. Abdelrahman and Kincaid (1993) measured liver Se concentration in fetuses of various 
ages removed from cows at slaughter and found that, on average, Se concentration increased 
from d 145 to d 195, but then decreased from d 195 to d 245. The researchers concluded that this 
decrease in liver Se concentration during late gestation might possibly reflect an increase in the 
synthesis of selenoproteins such as GPx by the fetus prepartum, and therefore an increased need 
for Se by the fetus. A study performed by Weiss et al. (1984) found that Holstein calves from 
cows fed 0, 1, or 5 mg of supplemental Se as sodium selenite 60 d before parturition had serum 
Se concentrations that mirrored that of their respective dams. When the serum Se concentrations 
of calves at birth were regressed against serum Se concentrations of their dams at 60 d 
prepartum, or d 0 of the trial, there was virtually no correlation (r
2 = 0.01). However, when the 
serum Se concentrations of the same calves were then regressed on the serum Se concentrations 
of their dams at 45, 30, 15, and 0 d prepartum, there was significant correlation (r
2  = 0.79, 0.79, 
0.83, and 0.73, respectively). Furthermore, calves whose dams received 1 mg supplemental Se 
maintained higher serum Se concentration longer than those calves whose dams received no 
supplemental Se. The researchers interpreted this data to suggest that Se concentration in the 
blood of prepartum cows can be used to predict neonatal calf Se status and that supplementation 
of the dam may be a method of increasing calf Se concentrations before parturition. In addition, 
cow Se status may also continue to play a significant role in the Se status of their calves after 
parturition, primarily if calves continue to suckle cows, as occurs in beef cattle, since Se is also 
transferred through the milk of lactating females (Rowntree et al., 2004; Bruzelius et al., 2007). 
  13Ammerman et al. (1980) reported that kidney and liver Se concentrations of calves suckling 
cows maintained on a diet consisting of approximately 0.2 ppm Se (0.1 ppm occurring naturally 
and 0.1 ppm supplemented Se) and having an average liver Se concentration of 0.2 ppm were 
1.22 and 0.11 ppm, respectively. 
Given the wide range of Se concentrations and the considerable amount of variability 
between different laboratories, some researchers have attempted to provide ranges of Se 
concentrations for use as a Se status guideline. In the review titled “Biochemical and 
Physiological Indicators of Selenium Status in Animals” (1987), Ullrey states that plasma Se 
concentrations of 0.08 to 0.12 ppm may be considered adequate. The Michigan State University 
Animal Health Diagnostic Laboratory has also attempted to provide such ranges for reference. 
According to their laboratory, normal plasma selenium concentrations for adult cattle are 
expected to range from 0.070 to 0.100 ppm and serum selenium values generally increase 
gradually as animals age, with initial serum selenium values of approximately 0.050 to 0.080 
ppm for neonates considered normal (Stowe and Herdt, 1992). The Michigan State University 
Animal Health Diagnostic Laboratory analyzed serum samples for cattle of various ages and 
found that, on average, young calves aged 10 to 29 days of age had serum selenium 
concentrations between 0.055 and 0.075 ppm, and between days 30 and 180 of age, calves 
typically had serum selenium concentrations between 0.060 and 0.080 ppm (Stowe and Herdt, 
1992). According to Gerloff (1992), marginally Se-deficient adult cattle generally have plasma 
selenium concentrations between 0.040 and 0.070 ppm, while adult cattle with concentrations 
below 0.040 ppm are considered deficient. Liver selenium concentrations generally range 
between 1.2 and 2.0 ppm on a dry weight basis and are typically consistent in normal animals of 
adequate selenium status, regardless of animal age (Stowe and Herdt, 1992).  
  14Although plasma, whole blood, and tissue selenium concentrations are commonly 
measured, these response variables are not generally recognized as being accurate indicators of 
selenium status (Gerloff, 1992). This is primarily due to the fact that Se may be absorbed in one 
of two forms, inorganic, usually as sodium selenite, or in the organic form, most commonly as 
selenomethionine (SeMet), which is incorporated nonspecifically into protein as an amino acid in 
which the sulfur residue has been replaced by Se. Selenomethionine is not incorporated into Se-
dependent GPx, considered to be one of the most common functional forms of Se, thus assay for 
Se in whole blood, serum, plasma, or other tissues alone may not provide an accurate depiction 
of functional Se status (Burk, 1991). In fact, an increase in tissue Se concentration is not always 
associated with a corresponding increase in GPx activity (Lane et al., 1979; Elsey et al., 1983; 
Whanger and Butler, 1988). In addition, when serum Se concentration was regressed via simple 
linear regression on whole blood Se concentration, the correlation coefficients were moderately 
high (r
2=0.62 and 0.88 for HG-AAS data and ICP data, respectively). However, prediction 
intervals calculated from these correlation coefficients for estimating whole blood Se from serum 
Se were very wide (Maas, 1992). For this reason, most conclude that serum Se concentration is 
not necessarily an appropriate indicator of nutritional Se status. The researchers theorized that 
these wide intervals were possibly due to short-term changes in serum Se concentration due to 
variable Se intake short-term, whereas whole blood, or erythrocyte, Se concentration reflects 
more long-term Se status (Maas, 1992). Given these drawbacks to the sole use of Se 
concentration as an indicator of Se status, GPx activity is generally considered a more accurate 
indicator of Se status, but not all forms of the enzyme serve equally in this role.  
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The role of Se in the body is primarily as an antioxidant via the Se-dependent glutathione 
peroxidases (Arthur et al., 2003). Using erythrocytes extracted from rats maintained on either a 
Se-adequate or Se-deficient diet, Rotruck et al. (1973) found that hemoglobin oxidation was 
increased in the erythrocytes of rats maintained on the Se-deficient diet. Further investigation by 
the group showed that Se was a “necessary and integral” part of the GPx enzyme. In addition, 
Flohe et al. (1973) showed that the GPx enzymes contained 4 g atoms of Se mol
-1. Since the 
discovery of Se in the active site of GPx by Rotruck et al. (1973) and Flohe et al. (1973), four 
primary Se-dependent GPx enzymes have been identified: Classical Glutathione Peroxidase 
(GPx-1; EC 1.11.1.9), Gastrointestinal Glutathione Peroxidase (GPx-2; 1.11.1.9), Plasma 
Glutathione Peroxidase (GPx-3; 1.11.1.9), and Phospholipid Hydroperoxide Glutathione 
Peroxidase (GPx-4; EC 1.11.1.2). Each of the Se-dependent GPx enzymes, with the exception of 
GPx-4 (Lei et al., 1995), is a homotetramer (Takahashi et al., 1987) containing one 
selenocysteine per subunit in the active site of the enzyme (Forstrom et al., 1978) and each 
subunit has a molecular mass of approximately 19 kD (Epp et al., 1983). The primary function of 
the GPx enzyme is as an antioxidant responsible for catalysis of the reaction in which glutathione 
(GSH) in the reduced form is used to reduce cellular reactive oxygen species (ROS), primarily 
hydrogen peroxide (H2O2), common byproducts of cellular metabolism and processes involving 
oxygen (Flohe, 1973). These strong oxidants have the potential to react with cellular 
macromolecules and cause damage such as genomic mutations, destruction of protein structure 
and function, and lipid peroxidation, which may, in turn, result in considerable cellular oxidative 
stress and even cell death (Halliwell et al., 1992; Poot, 1991). In order to avoid such damage, 
these ROS are converted to water (H2O) or, in the case of organic hydroperoxides, non-toxic 
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donor to the oxidized GSH, returning it to the active reduced form. Specifically, two glutathione 
molecules are oxidized to form two molecules of water from one molecule of H2O2 via the 
catalytic enzyme GPx. The oxidized glutathione (GSSG) is then reduced via catalysis by the 
enzyme glutathione reductase (GSSG-R) to reform two molecules of glutathione (Paglia and 
Valentine, 1967) (Figure 2.1).   
2 GSH + H2O2 ----
GPx----Æ 2 H2O + GSSG + NADPH  --
GSSG-R--Æ 2 GSH + NADP
-. 
Figure 2.1. The oxidation and subsequent reduction of GSH, from Paglia and Valentine (1967). 
Glutathione Peroxidase-1 (GPx-1) 
Since the discovery (Mills, 1957) and partial purification (Mills, 1959) of GPx, numerous 
forms of the enzyme have been isolated and purified in various body tissues. The form of GPx 
contained within the cell cytosol and mitochondria is GPx-1, or cytosolic GPx (Chambers et al., 
1986; Esworthy et al., 1997). The highest activity of this enzyme is generally considered to be in 
the liver, followed by the erythrocytes, lungs, and heart (Ullrey, 1987). Considerable research 
has shown that GPx-1 functions primarily in an anti-oxidant role, its primary substrate being 
H2O2 and other organic hydroperoxides. Using GPx knockout mice possessing a homozygous 
null mutation for GPx-1, Haan et al. (1998) demonstrated that the enzyme has a significant role 
in the protection of cells from paraquat-induced oxidation. The GPx-1 knockout mice were 
shown to have significantly increased mortality when exposed to 30 ppm paraquat, with 100% of 
knockouts dying within 5 hours of exposure, versus the controls, which showed no evidence of 
toxicity. The group also showed that cortical neurons, when challenged directly with H2O2, were 
considerably more susceptible to oxidative damage in the knockout mice than in the control 
group. Furthermore, Haan et al. (1998) showed that exposure to paraquat transcriptionally up-
  17regulated GPx-1 in normal cells, reinforcing the importance of the enzyme in protection from 
oxidative stress. Recent studies utilizing GPx-1 knockout mice also have shown that these 
animals are actually healthy and fertile up to 15 month of age, showing no considerable growth 
response which may be attributed to Se-deficiency or, as a result, GPx-1 deficiency (Ho et al., 
1997; Cheng et al., 1997). These findings agree with other observations using Se-deficiency to 
induce a decrease in GPx activity in various species (Christiansen and Burgener, 1992; Lei et al., 
1995; Mahan and Parrett, 1996; Weiss et al., 1996; Lei et al., 1998; Haan et al., 1998; Lawler et 
al., 2004; Payne and Southern, 2005). These reports are in conflict with findings of Whanger and 
Butler (1988) in which rats fed a basal diet containing 0.02 ppm Se gained significantly less than 
those rats fed a diet supplemented with varying levels of Se. However, the researchers reported 
that the rats consuming the basal diet consumed significantly less feed than those rats fed the 
basal diet supplemented with varying levels of Se. 
Glutathione Peroxidase activity in blood is associated largely with erythrocytes, which 
contain approximately 98% of total GPx-1 activity (Scholtz and Hutchinson, 1979). The enzyme 
is incorporated into reticulocytes, the precursors of erythrocytes, during their formation with 
whole-body erythrocyte turnover only occurring approximately every 90 to 120 days in the 
bovine (Ullrey, 1987), marking erythrocyte GPx-1 (RBC-GPx) activity as an ideal estimator of 
long-term Se status. However, there are notable inter-species variations with regard to GPx 
activity in erythrocytes. A comparison of GPx activity in nine species was published by Suzuki 
et al. (1985). The means of the nine species ranged from 22 EU/g hemoglobin (Hb) in the golden 
hamster to 493 EU/g Hb in the mouse, where one enzyme unit (EU) is equal to the amount of 
GPx activity required to oxidize 1 µmol NADPH per min. The GPx activity in the erythrocytes 
of cattle was reported to be 165 ± 43 EU/g Hb (Suzuki et al., 1985) (Table 2.4). A study 
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had an average RBC-GPx activity of 47 ± 11 EU/g Hb. When rats were fed the basal diet 
supplemented with 0.2 ppm Se or 1.0 ppm Se a sodium selenite, they had an average RBC-GPx 
activity of 435 ± 19 EU/g Hb and 518 ± 21 EU/g Hb, respectively (Table 2.5). Weiss et al. 
(1996) found that RBC-GPx activity in Se-deficient rats maintained on a diet containing 0.007 
ppm Se was 40 ± 3% of the activity in Se adequate female rats fed a diet containing 0.1 ppm Se 
as sodium selenite. Erythrocyte GPx-1 activity ranged from approximately 80 EU/ g Hb for rats 
consuming the Se-deficient basal diet containing 0.007 ppm Se to approximately 280 EU/g Hb 
for those rats fed a diet supplemented with 0.3 ppm Se as sodium selenite (Table 2.5). 
Erythrocyte GPx-1 activity has also been used as an indicator of Se status in cattle at 
various production stages. In a study examining the effect of pre- and post-partum Se 
supplementation on cows and their calves, cows consuming 13 mg Se/d for 15 d pre-partum had 
an average d 0 RBC-GPx activity of 2.33 EU/g Hb. When sampled at 15 and approximately 54 d 
post-partum, the same cows had an average RBC-GPx activity of 122.4 EU/g Hb and 127.2 EU/g 
Hb at  respectively. Calves from these cows had RBC-GPx activity of 186.2 and 129.3 EU/g Hb 
at 15 d and 54 d post-partum, respectively. In the same study, cows consuming 32.5 mg Se/d had 
an initial RBC-GPx activity of 1.67 EU/g Hb. When these cows were sampled at d 15 and 54 
post-partum, they had an average RBC-GPx activity of 161.7 and 181.1 EU/g Hb, respectively 
(Enjalbert et al., 1999). A second experiment conducted by the same group found that when 
cows were supplemented with 0, 13, or 32.5 mg Se/d for 15 d postpartum and sampled 
approximately 101 d post-partum, they had an average RBC-GPx activity of 67.2, 146.4, and 
150.9 EU/g Hb, respectively (Table 2.5). The calves of the same cows were treated with 1.38 mg 
Se intramuscularly on d 2 post-partum and again at approximately 49 d of age. When these 
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of 130.0, 156.4, and 177.1 EU/g Hb when their dams received 0, 13, or 32.5 mg Se/d, 
respectively (Enjalbert, 1999).  In a study conducted by Rowntree et al. in 2004 involving 
Table 2.4. Average RBC-GPx-1 Activity of Animals and Humans, from Suzuki et al., 1985. 
Species EU/g  Hb
a,b 
Golden hamster  22 ± 2 
Guinea Pig  28 ± 6 
Rabbit  33 ± 7 
Rat  106 ± 20 
Mouse    493 ± 124 
Goat  115 ± 53 
Sheep  124 ± 41 
Cattle  165 ± 43 
Human  35 ± 7 
a Mean ± 95% confidence limits. 
b EU= Enzyme Unit; 1 EU is the amount GPx activity required to oxidize 1 µmol NADPH per   
 min.  
 
multiparous Hereford cows, erythrocyte GPx activities in cows unsupplemented with Se were  
14.94 EU/g Hb, while RBC-GPx activity in cows supplemented with Se was 24.61 EU/g Hb 
(SEM=3.33).  
Glutathione Peroxidase-1 is also found in animal tissues, most notably the liver, lungs, 
and heart (Ullrey, 1987). It is often desirable to examine GPx-1 activity in tissues in an attempt 
to both accurately determine Se status and to correlate tissue activity to tissue Se concentrations 
and GPx-1 mRNA concentrations. Liver is often used for this purpose as it has been shown to 
have the highest GPx activity of any tissue that has been analyzed (Behne and Wolters, 1983). 
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concentration (r
2= 0.73) and, to a lesser extent, blood Se concentration (r
2= 0.69). Liver GPx-1 
activity is also highly responsive to Se status. Liver GPx activity in Se-deficient rats has been 
Table 2.5. Erythrocyte GPx-1 activity in various species fed varying levels of Se. 
Author Year  Species  [Se] in diet, 
ppm 
RBC-GPx-1, 
EU/g Hb
a
Whanger and 
Butler  1988  Rat   0.02  47 ± 11
Whanger and 
Butler  1988  Rat             0.2  435 ± 19
Whanger and 
Butler  1988  Rat             1.0       518 ± 21
Weiss et al.  1996  Rat     0.007           80 
Weiss et al.  1996  Rat             0.3         280 
Enjalbert et al.  1999  Cow           10
b,c                  67.2
d 
Enjalbert et al.  1999  Cow           13
b              146.4
d 
Enjalbert et al.  1999  Cow           32.5
b              150.9
d 
Rowntree et al.  2004  Cow  No supplemental                14.94 
Rowntree et al.  2004  Cow  20 mg drench                24.61 
a EU= Enzyme Unit; 1 EU is the amount GPx activity required to oxidize 1 µmol NADPH per   
  min. 
b mg Se d
-1. 
c supplemented for 15 d postpartum. 
d at 101 d post-partum. 
 
previously reported to be as little as 8% of that observed in rats maintained on a Se-adequate diet 
formulated to contain 0.5 ppm Se (Lawrence and Burk, 1976). Whanger and Butler (1988) found 
that rats maintained on a Se-deficient basal diet containing 0.02 ppm Se had an average liver 
GPx activity of 8 ± 4 EU/g protein, while rats fed the basal diet supplemented with 0.2 ppm Se 
as sodium selenite had an average liver GPx activity of 700 ± 105 EU/g protein (Table 2.6). 
Weiss et al. (1996) reported average liver GPx-1 activity of rats consuming a basal diet 
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rats fed a diet containing 0.1 ppm Se as sodium selenite. In this study, the liver GPx activity of 
the supplemented rats was, on average, approximately 2,400 EU/g protein (Table 2.6). Liver 
GPx-1 activity levels have also been determined in swine; growing pigs maintained on a Se-
deficient basal diet containing 0.03 ppm Se were found to have an average liver GPx-1 activity 
of approximately 12.5 EU/g protein, while pigs fed the basal diet supplemented with either 0.1 or 
0.3 ppm Se as sodium selenite had average liver GPx-1 activities of 50 and 210 EU/g protein, 
respectively (Lei et al., 1998, Table 2.6).  
Table 2.6. Liver GPx-1 activity in various species fed varying levels of Se. 
Author Year  Species  [Se] in diet, 
ppm 
Liver GPx-1, 
EU/g protein
Whanger and 
Butler  1988  Rat    0.02            8 ± 4 
Whanger and 
Butler  1988  Rat  0.2  700 ± 105
Weiss et al.  1996  Rat      0.007           <   100 
Weiss et al.  1996  Rat  0.1      2,400 
Lei et al.  1998  Pig    0.03              12.5 
Lei et al.  1998  Pig  0.1            50 
Lei et al.  1998  Pig  0.3          210 
 
Glutathione Peroxidase-3 (GPx-3) 
In comparison to that of erythrocytes, plasma Se levels are more sensitive to short-term 
changes in Se supplementation and tend to fluxuate depending on Se concentration, frequency of 
Se intake, and even hydration status. Thus, extracellular plasma GPx-3 activity is considered to 
reflect short-term Se status and is considered inappropriate as a long-term indicator of Se status  
  22(Gerloff, 1992). Since its discovery in 1986 (Takahashi and Cohen), research has shown that 
GPx-3 is actually regulated separately from GPx-1, illustrated in part by research showing that 
Se repletion results in an increase in GPx activity at different times for erythrocytes versus 
plasma. Plasma GPx activity increases relatively quickly in comparison to the rate of increase of 
RBC-GPx activity, for which there is a significant lag-time of approximately four to five weeks 
in humans. This lag is due to the fact that GPx-1 may only be incorporated into the erythrocyte 
during erythropoiesis (Cohen et al., 1985). An additional experiment in which rats both 
genetically altered to overexpress GPx-1 and GPx-1-normal rats were fed either a diet adequate 
or deficient in Se further supports the work of Cohen et al. (1985). In this experiment, the 
overexpression of GPx-1 failed to have any bearing on the expression of GPx-3 (Cheng et al., 
1997). In addition, when GPx-1 knockout mice were fed one of two diets containing either 0.002 
ppm Se or 0.5 ppm supplemented Se as sodium selenite, researchers observed no effect of the 
knockout of the GPx-1 gene on GPx-3 activity or GPx-3 mRNA expression in the kidney (Cheng 
et al., 1997). Whereas the primary site of GPx-1 synthesis is the liver, the primary site of GPx-3 
mRNA and protein synthesis is the proximal tubules of the kidney (Avissar et al., 1994). 
Furthermore, sequencing of the purified protein (Esworthy et al., 1991) and its cDNA (Takahashi 
et al., 1990) have demonstrated that GPx-3 is a separate gene product from that of GPx-1, in 
spite of previous belief that the two resulted from post-transcriptional modification of the same 
gene.   
As with tissue Se concentration and GPx-1 activity, there is considerable inter-species 
and inter-lab variation with respect to reported activity (Ullrey, 1987). Lei et al. (1995) found 
that rats fed a basal diet containing 0.002 ppm Se had an average GPx-3 activity of 2.00 ± 0.58 
EU/g protein, while rats fed a diet supplemented with 0.130 ppm Se as sodium selenite had an 
  23average GPx-3 activity of 95.33 ± 14.15 EU/g protein (Table 2.7). Weiss et al. (1996) found that 
plasma GPx-3 activity in rats fed a Se-deficient basal diet was 8 ± 1% that of rats fed a diet 
supplemented with 0.1 ppm Se as sodium selenite. Plasma GPx-3 activity for the deficient rats 
was approximately 1.0 EU/g protein while activity for rats maintained on a diet supplemented 
with 0.1 ppm of diet was approximately 800.0 EU/g protein (Table 2.7). Research with swine has  
Table 2.7. GPx-3 activity in various species fed varying levels of Se. 
Author Year  Species  [Se] in diet, 
ppm 
GPx-3 activity, 
EU/g protein
a
Lei et al.  1995  Rat  0.002        2 ± 0.58 
Lei et al.  1995  Rat  0.130  95.33 ± 14.15
Weiss et al.  1996  Rat  0.007        1.0 
Weiss et al.  1996  Rat            0.1    800.0 
Lei et al.  1998  Pig            0.03     < 1.0 
Lei et al.  1998  Pig            0.1   > 10.0 
Lei et al.  1998  Pig            0.3    >15.0 
Southern and 
Payne  2005 Chicken  (Broiler) 0.067     < 0.1×10
5 –       
0.05×10
5 
Southern and 
Payne  2005  Chicken (Broiler)            0.3  3×10
5 – 
3.5×10
5 
Rowntree et al.  2004  Mulitparous cow  No supplemental        0.92 
Rowntree et al.  2004  Multiparous cow  20 mg drench        1.34 
a EU= Enzyme Unit; 1 EU is the amount GPx activity required to oxidize 1 µmol NADPH per   
  min. 
shown that pigs fed a basal diet containing 0.03 ppm Se had an average GPx-3 activity of less 
than 1.0 EU/g protein after 35 d on the diet (Lei et al., 1998). Pigs fed the basal diet 
supplemented with either 0.1 ppm Se or 0.3 ppm Se as sodium selenite had an average GPx-3 
activity of greater than10 EU/g protein and greater than15 EU/g protein, respectively, after 35 
days on their respective diets (Lei et al., 1998, Table 2.7). Southern and Payne (2005) performed 
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corn-soybean meal diet containing 0.067 ppm Se with no supplemented Se or the basal diet 
supplemented with 0.3 ppm Se as sodium selenite for 10 d, broilers had an average GPx-3 
activity of less than 0.1 x 10
5 EU/g protein and between 3 and 3.5 x 10
5 EU/g protein, 
respectively (Table 2.7). In addition, when the broilers initially fed the Se supplemented diet 
were then fed the Se-deficient basal diet for an additional 12 d, GPx-3 activity fell to between 0.1 
and 0.05 x 10
5 EU/g protein. GPx-3 activity of the broilers maintained on the Se-deficient basal 
diet for the full 22 d period decreased only slightly further to 0.05 x 10
5 EU/g protein. In a study 
conducted by Rowntree et al. in 2004 involving multiparous Hereford cows, plasma GPx-3 
activities were reported to be 0.92 EU/g protein in unsupplemented cows versus 1.34 EU/g 
protein in supplemented cows (Table 2.7). 
Selenium Regulation of GPx 
  Selenium is found in the active site of all Se-dependent GPx enzymes, thus marking the 
element as a significant regulator of Se-dependent enzyme activity, especially the activity of 
GPx-1 (Sunde, 1997). The decrease in enzyme activity during Se-deficiency is due to a decrease 
in the level of the GPx enzyme protein (Knight and Sunde 1987; Knight and Sunde, 1988). Most 
studies examine the effect of Se-deficiency on GPx-1 activity, as it is the most dramatically 
affected GPx enzyme (Weiss and Sunde, 1998). This is primarily because GPx-1 appears to 
compete for Se less efficiently than other selenoproteins in nutritional Se-deficiency (Lei et al., 
1995). In addition to a loss in enzyme activity, a significant decrease in GPx mRNA is also 
observed in Se-deficiency, resulting in a reduction of liver GPx-1 mRNA levels to less than 10% 
of those levels observed in Se-adequate rats (Saedi et al., 1988; Yoshimura et al., 1988; 
Christensen and Burgener, 1992; Hill et al., 1992). Although all of the Se-dependent GPx 
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(Moriarty et al., 1998).When comparing the Se regulation of GPx-1 mRNA to other 
selenoprotein mRNAs, most researchers have found that GPx-1 mRNA levels decrease 
considerably in Se-deficiency, whereas the levels for most other selenoproteins are affected less 
dramatically (Hill et al., 1992; Lei et al., 1995; Weiss et al., 1997). In fact, GPx-4 mRNA levels 
are not significantly reduced in Se-deficiency (Lei et al., 1995), although GPx-1 and 4 share 
approximately 40% homology in their nucleotide sequences (Sunde et al., 1993). This down-
regulation has been further shown to be specific for GPx-1 mRNA using Se-repletion studies in 
which rats were first maintained on a Se-deficient diet and were then fed a diet adequate in Se. 
While internal control genes such as Poly-A polymerase mRNA, 18S rRNA, and β-actin mRNA 
levels remained unaffected by Se-deficiency, GPx-1 mRNA levels dropped dramatically (Lei et 
al., 1995; Bermano et al., 1996; Weiss et al., 1996; Weiss et al., 1997). When the rats were then 
fed a diet adequate in Se, GPx-1 activity and mRNA levels increased rapidly. However, in spite 
of the rapid decrease observed in GPx-1 activity and level during Se depletion followed by the 
rapid increase observed in both during Se repletion, GPx-1 transcription levels are not affected 
by deficiency (Toyoda et al., 1990; Christensen and Burgener, 1992). Furthermore, transcription 
of the Se-dependent GPx genes by cultured cells are minimally effected by the availability of Se 
in the culture medium (Chada et al., 1989) and the transport of GPx mRNA out of the nucleus of 
the cell has also been shown to be unaffected by Se status (Sugimoto and Sunde, 1992). In 
addition, studies utilizing isolated rat liver cells showed that Se-deficiency reduced the relative 
abundance of cytoplasmic GPx-1 mRNA but did not have any effect on nuclear GPx-1 mRNA 
(Moriarty et al., 1998). These results have led researchers to conclude that the regulation of GPx 
by Se is via a posttranscriptional mechanism (Sunde, 1994) and that induced Se deficiency 
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cytoplasmic mRNA via nonsense-codon-mediated decay (Moriarty et al., 1998). 
  The SECIS Element and UGA-mediated Nonsense Decay 
  All eukaryotic selenoprotein mRNAs contain a cis-acting element in the 3’untranslated 
region (UTR) that is required for the insertion of Se (Kinzy et al., 2005). This sequence is known 
as the selenocysteine insertion sequence, or SECIS element, which consists of an RNA hairpin 
loop composed of two helices separated by an internal loop (Walckzak et al., 1996; Martin et al., 
1998). This loop contains two highly conserved sequences: four non-Watson and Crick base 
pairs consisting of UGAU and AAA in the stem and loop, respectively (Shen et al., 1993). The 
four consecutive non-Watson and Crick base pairs located within the core of helix 2 are 
responsible for conveying a structural/functional motif that is necessary for selenocysteine (Sec) 
insertion during translation (Walczak et al., 1996; Walczak et al., 1998). In addition, a UGA 
codon, which normally signals translational termination, is located within the open reading frame 
and, in combination with the SECIS element located downstream within the 3’ UTR, codes for 
the insertion of Sec, the 21
st amino acid and the form in which Se is incorporated into 
selenoproteins (Berry et al., 1991; Berry et al., 1993; Low and Berry, 1996). The recognition of 
this codon as an insertion sequence for Sec requires the presence of Se and a metabolic pathway 
that converts Se to selenocysteinyl-tRNA (tRNA
sec) (Moriarty et al., 1998). Research has shown 
that adding the GPx stem-loop structure to mRNA encoding a protein normally lacking a Se 
moiety resulted in the inclusion of Sec in the protein and subsequent Se regulation. The 
researchers interpreted this as an indication that the GPx 3’-UTR alone is adequate for signaling 
the translation of a UTR as Sec (Shen et al., 1993). However, further work has shown that Sec 
incorporation also requires three additional trans-acting elements, a Sec-specific translation-
  27elongation factor (eEFSec), SECIS binding protein 2 (SBP2), and ribosomal protein L30 (rpL30) 
(Kinzy et al., 2005). 
  In addition to contributing to the incorporation of Se into selenoproteins, the combined 
function of the UGA codon and the SECIS element are considered to be responsible for 
mediating the nonsense decay of cytoplasmic GPx mRNA in the absence of adequate Se 
(Moriarty, 1998). The modification of cytosolic mRNA turnover by a nutrient for the regulation 
of eukaryotic gene expression is not an unusual concept. In numerous cases, the availability of 
nutrients serves to alter gene expression for products that are relevant to their metabolism 
(Christensen and Burgener, 1992). Iron availability, for example, can alter the expression of 
transferrin by the binding of iron to the cytosolic transferrin mRNA receptor, which in turn 
stabilizes the mRNA, protecting it from degradation (Klausner and Harford, 1989; Müllner et al., 
1989). In addition, there are numerous organisms including various species of bacteria, yeasts, 
and vertebrates that have mechanisms for the elimination of mRNAs that have prematurely 
terminated because of frameshift or nonsense mutations (Peltz et al., 1994; Maquat, 1995; Ruiz-
Echevarria, 1996). Interestingly, the majority of mammalian cells that have been studied have 
mRNAs that are degraded while associated with the nucleus (Maquat, 2005); however, 
selenoprotein mRNAs decay after transport into the cytoplasm, underlined by the fact that Se-
deficiency results in a decrease in cytoplasmic GPx-1 mRNA but not in a decrease in nuclear 
GPx-1 pre-mRNA or mRNA (Moriarty, 1998). The combined work of Weiss and Sunde (1997) 
and Moriarty (1998) suggest that the combination of the UGA codon and the SECIS element are 
required for the decrease in GPx-1 mRNA abundance as a result of Se-depletion. Kinzy et al. 
(2005) reinforced this model of UGA codon nonsense-mediated decay while characterizing the 
SBP2 complex. According to his group, during translation, when the ribosome pauses at the 
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SBP2 binds to the SECIS element, it briefly releases the ribosome, allowing access to the 
ribosomal A-site and incorporation of the tRNA
sec via the eEFSec/tRNA
sec complex. In the 
absence of Se, there is no t-RNA
sec to add Sec to the growing protein and translation is thus 
terminated. It is currently unknown whether the nonsense-mediated decay of the mRNA that 
follows occurs while the truncated protein and mRNA are still associated with the ribosome or if 
it occurs within “cytoplasmic foci”, ribosome-free sites of general mRNA decay (Maquat, 2005). 
Incorporation of Se into GPx and Other Selenoproteins 
Selenocysteine is located 41 residues from the N-terminal end of rat liver GPx (Condell 
and Tappel, 1982), 45 residues from the end of bovine GPx (Gunzler et al., 1984), and 47 
residues from the end of murine GPx (Chambers et al., 1986). In 1987 Sunde and Evenson 
elucidated the origin of the Sec residue by perfusing isolated rat liver with amino acids labeled 
with either C
14 or H
3. They determined that the skeletal precursor to Sec was not cysteine, as 
previously thought, but serine (Ser).  
The formation of Sec outlined by Burk (1991) is based primarily on the mechanism as is 
understood in E. coli and requires both a Ser-charged tRNA and a source of selenide. However, 
there are indications that a similar scheme exists in mammals (Burk, 1991; Hubert et al., 1996; 
Kinzy et al., 2005) This mechanism requires a unique tRNA (tRNA
[ser]sec) that is first charged 
with a Ser residue by the catalytic enzyme seryl-tRNA synthetase, as Sec synthesis occurs on its 
tRNA (Driscoll and Copeland, 2003). The Ser must then be activated to phosphoseryl-
tRNA
[ser]sec before it can be replaced by Se. It is thought that this step is carried out by a kinase in 
animals, but the specific mechanism is not currently known (Lee et al., 1989). The conversion of 
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[ser]sec to tRNA
sec with selenophosphate as the Se donor is then catalyzed by 
selenocysteine synthase (Hubert et al., 1996) (Figure2.2). 
   Step 1    tRNA
[ser]sec + serine ----
seryl-tRNA ligase-----Æ seryl-tRNA
[ser]sec 
   Step 2    seryl-tRNA
[ser]sec -----
kinase?-------Æ phosphoseryl-tRNA
[ser]sec 
Step 3    phosphoseryl-tRNA
[ser]sec + selenophosphate ---
selenocysteine synthase---Æ tRNA
sec 
Figure 2.2. Eukaryotic selenocysteine synthesis, from Burk (1991), with changes. 
 
The addition of Sec to selenoproteins, including GPx, is a co-translational event in which 
the UGA codon codes for the addition of Sec via tRNA
sec.  As previously outlined, during 
translation of the selenoprotein mRNA, SBP2 is bound to the translating ribosome. The 
elongation factor eEFsec serves to escort tRNA
sec to the ribosomal A-site (Fletcher et al., 2001). 
When the ribosome arrives at the UGA codon, it pauses, allowing SBP2 to recognize both 
specific nucleotides within the SECIS element and the eEFSec/tRNA
sec complex. SECIS binding 
protein 2 then binds both the SECIS element and eEFSec and is temporarily released from the 
ribosome, allowing the eEFSec/tRNA
sec complex access to the UGA codon within the ribosomal 
A-site and subsequent incorporation of Sec instead of translation termination. The addition of 
Sec also results in an alteration of the SECIS element conformation. Once the tRNA has 
dissociated from the ribosome, the third protein necessary for the completion of Sec 
incorporation, rpL30, binds to the now altered SECIS element, releasing SBP2 and allowing its 
re-association with the ribosome (Kinzy et al., 2005). 
Quantification of the GPx Enzyme mRNAs 
  In addition to tissue Se concentrations and activity of various GPx enzyme tissue 
activities, comparison of relative GPx mRNA levels is often a desirable method of determining 
Se status. However, as previously mentioned, not all selenoprotein mRNA levels are affected 
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prioritization concerning selenoprotein expression in Se-deficiency. Some selenoprotein 
mRNAs, such as GPx-4 mRNA, are affected very little by a decrease in Se availability, whereas 
others, such as GPx-1 mRNA, are affected fairly dramatically. Despite all that is currently 
known about selenoproteins and their regulation, the specific mechanisms by which this 
regulatory process occurs are complex and currently poorly understood (Bruzelius et al., 2007).  
The utilization of polymerase chain reaction (PCR) in mRNA quantification is considered 
appropriate due to its high sensitivity, especially in detecting relatively small quantities of 
product (Moriarty et al., 1998). High detection sensitivity and accuracy are both desirable 
characteristics when determining relative quantities of mRNA, especially when n-fold 
differences between samples may be as small as 2; Real-time PCR (Q-PCR) has been shown to 
consistently provide both of these qualities (Cheng and Maquat, 1993; Moriarty et al., 1998).  
  Because of its extreme sensitivity to Se status, GPx-1 mRNA is considered an acceptable 
candidate for comparison of mRNA levels as an indicator of Se status. Research has shown that 
GPx-1 mRNA levels reliably decrease during Se-deficiency (Christensen and Burgener, 1992; 
Weiss et al., 1996; Lei et al., 1998; Moriarty, 1998). Glutathione peroxidase-1 mRNA levels 
have also been used as a parameter contributing to the determination of dietary Se requirement 
within a specific species and sex during specific developmental stages (Weiss et al., 1996). In 
fact, comparison of male rat liver GPx-1 mRNA to that of female rats showed that female rats 
had mRNA levels that were 0.7 fold higher, when both sexes were maintained on a diet 
containing 0.1 ppm Se as sodium selenite (Weiss et al., 1996). Christensen and Burgener (1992) 
report a 93-95% reduction in GPx-1 mRNA hybridization in rats fed a Se-deficient diet 
containing 0.02 ppm Se versus rats fed a diet supplemented with 0.5 ppm Se as sodium selenite. 
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had liver GPx-1 mRNA levels that were 11 ± 1 % of that observed in female rats fed the basal 
diet supplemented with 0.1 ppm Se as sodium selenite. Other researchers using rats or mice 
maintained on a Se-deficient diet for a period of time ranging from 42-135 d have reported 
decreases in liver GPx-1 mRNA levels in animals of as much as 80-90% (Saedi et al., 1988; 
Toyoda et al., 1990; Lei et al., 1995). Relative mRNA levels have also been used as an indicator 
of Se status in some livestock species, but its use is thus far rare. In fact, the only livestock 
species in which the effect of Se-deficiency on relative mRNA GPx-1 levels has been determined 
is the pig. Lei et al. (1998) reported a 50% relative decrease in liver GPx-1 mRNA levels for pigs 
maintained for 5 wks on a Se-deficient diet containing 0.03 ppm Se versus pigs maintained for 
the same time period on a diet supplemented with 0.2 ppm Se. In contrast, Hostetler et al. (2006) 
reported finding no significant difference in sow liver GPx-1 mRNA level when sows were fed 
diets consisting of barley and peas grown in Se-deficient soils and either supplemented or 
unsupplemented with Se as sodium selenite. Their diets were analyzed as containing 0.05 ppm 
Se in the Se-deficient diet and 0.39 ppm Se in the Se adequate diet. However, the researchers 
concluded that, based on the GPx activities and mRNA levels that they observed in the livers of 
the sows, the sows were actually not Se-deficient, but instead were of marginal Se status. Taken 
with the work of Lei et al. (1998), this suggests that the margin of Se required to obtain Se-
deficient status based on GPx-1 mRNA level may be relatively small in domestic livestock 
species, requiring extremely low levels of Se to achieve Se-deficiency sufficient to significantly 
decrease levels of liver GPx-1 mRNA.  
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There is ever-increasing evidence suggesting the close relationship of nutritional status to 
immunity in livestock animals and even humans (Failla, 2003; Chirase, et al.,1991). It has been 
widely shown that nutrient-deficient hosts often develop more severe pathology than their 
nutritionally-adequate counterparts when challenged with a viral infection. Antioxidants have 
long been considered important in immune function and have recently been studied closely to 
determine their particular role in combating host oxidative stress (Beck, 1999). In particular, the 
trace mineral Se and the fat-soluble vitamin E have been of considerable interest, as it has been 
shown that Se deficiencies often result in numerous disease states that are often associated with a 
concurrent deficit in vitamin E (Turner and Finch, 1991; Wichtel, 1998; Beck and Levander, 
2000). Other trace minerals have also been considered to have some antioxidant or immune 
function, including Fe, Zn, and Cu, and data tend to support the conclusion that inadequate 
supply of such essential micronutrients is closely related to a decrease in the activities of cells 
intimately involved in the immune response (Failla, 2003; Hatfield, 2002). A deficiency in Se 
has been shown to have adverse effects on host immunity and host ability to adequately respond 
to and clear virus following an infection (Beck, 1999). This decrease in immune effectiveness as 
a result of selenium deficiency may be due to a decrease in host immune cellular function or 
even changes in the virus itself brought about by exposure to increased levels of ROS (Beck, 
1999). 
In addition to direct effects of Se-deficiency on the immune system, anti-oxidation 
suppression has been shown to influence viral agents. A number of studies have convincingly 
demonstrated that a non-virulent strain of the Picornavirus Coxsackievirus B3 will become a 
virulent strain of the virus in Se-deficient mice. When infected with a non-virulent strain of 
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Coxsackievirus B3, Se-deficient mice develop cardiomyopathy. (Beck, 1994a; Beck 1994b; 
Beck 1994c; Beck 1995; Beck 1998). Furthermore, when virus isolated from the Se-deficient 
mice was used to infect Se-adequate mice, the Se-adequate mice then too developed severe 
cardiomyopathy. These results demonstrated that replication of a normally benign virus in a Se-
deficient host could result in a virus with an altered genotype, such that increased pathogenicity 
occurred (Beck, 1999). The same result has been achieved by infecting Se-deficient mice with 
influenza virus (Beck, 2001). Interestingly, it was shown that the Se-deficiency had no effect on 
antibody response (Beck, 2001), suggesting that antibody titers alone may not be an adequate 
means for determining virulence or host ability to fight infection. Thus, Se-deficiency may prove 
to be a double-edged sword and further research into this area must be conducted to determine 
the extent to which Se-deficiency contributes to infectious disease.CHAPTER III 
THE INFLUENCE OF SE DEFICIENCY IN HOLSTEIN DAIRY CALVES ON TISSUE 
SE CONCENTRATION, GPX-1 AND 3 ACTIVITY, AND RELATIVE LEVELS OF 
LIVER GPX-1 MRNA  
Introduction 
  There has been considerable research concerning the effect of induced Se-deficiency on 
tissue Se concentration and GPx-1 and 3 activity in cattle of all sexes and ages. However, to our 
knowledge there is no data currently available concerning the effect of Se status on relative liver 
GPx-1 mRNA levels in growing calves. Given the considerable differences in results observed 
by various laboratories in a wide variety of species, we believe that it is not only necessary but 
also prudent to both establish ranges of GPx-1 and 3 activities for our laboratory and study the 
effect of Se-status on liver GPx-1 mRNA in growing calves. We hope to then use this data to 
further research the effects of Se-deficiency on oxidative stress in growing calves. 
Materials and Methods 
Experimental Design  
The LSU Agricultural Center Animal Care and Use Committee approved all animal 
procedures. Male Holstein calves (n=17), with a mean body weight of 42.96 kg, were purchased 
within one week after birth from the Southeast Research Station, Franklinton, LA. All calves 
were born between September, 2006 and December, 2006. Calves were housed individually at 
the Louisiana State University Agricultural Center Central Station, Baton Rouge, LA, in pens 
equipped with stainless steel bowl-waterers. Upon arrival, calves were administered 6 cc of 
Florfenicol subcutaneously and their navels dipped in 7% iodine solution. Each calf was then 
assigned an individual pen. Calves were fed a commercially available milk replacer (NutraBlend, 
Neosho, MO) containing 20% protein and 20% fat at 10% of birth weight twice daily until 21 d 
of age, at which time they were randomly assigned to either a Se-deficient (n=7) or Se-adequate 
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liver samples. Diet assignment was determined by pen location; pens were arranged so that Se-
adequate and Se-deficient animals were housed adjacent to one another in alternating fashion, 
both lengthwise down the barn and across the center isle dividing the barn. This arrangement was 
implemented in order to account for possible confounding variation in barn temperature, 
humidity, and availability of sunlight. Until 28 d of age, calves received 50% of their diet as 
commercial milk replacer and the rest as their respective starter diet. Beginning at 28 d of age 
calves were completely weaned to the starter phase of one of two diets: 
1)  Torula yeast basal diet containing no added Se (n = 7) 
2)  Torula yeast basal diet containing 0.1 ppm Se as sodium selenite (n = 7) 
Diets were fed in three phases (Reffett et al., 1988) (Table 3.1) and all calves remained on the 
initially-assigned Se-deficient or Se-adequate diet until trial completion. Calves were fed and 
disappearance measured and recorded twice daily. 
To ensure that exposure to exogenous sources of Se were minimal, water samples were 
collected from each of the automatic waterers and analyzed for Se concentration. The analyzed 
Se content of the water samples was less than 0.005 ppm Se. Analysis of calf diets showed that 
the Se adequate diet in phase 1 contained 0.158 ± 0.034 ppm Se, while the Se-deficient diet 
contained 0.025 ± 0.008 ppm Se.  
Selenium status of calves was determined by cytosolic GPx-1 and plasma GPx-3 activity. 
Jugular blood was collected every 28 d beginning at 28 d of age until trial completion. Calves 
were weighed upon arrival at the Central Research Station barn. Calves were then weighed on 14 
d of age and again every 14 d thereafter. Trial termination for each calf occurred upon reaching 
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and 168 d of age. 
As previously stated, three calves were euthanized via intravenous Phenobarbital 
injection at 21 d of age and liver tissue was collected and snap-frozen in liquid nitrogen and 
stored at -80º C in order to obtain a baseline (BSL) measurement for the group. Calves from each 
treatment (n=4) were then euthanized at 180 d of age for liver tissue collection and analysis. 
Liver tissue was wrapped in labeled aluminum foil and snap frozen in liquid nitrogen for storage 
at -80ºC. Messenger RNA was then isolated from each tissue sample for Q-PCR analysis and 
comparison. 
Table 3.1. Composition of Torula yeast based diet fed to calves, from Reffett et al., 1988. 
 
a Provesta Flavor Ingredients, Hutchinson, MN. 
 %   
 
Ingredient 
 
Starter Diet (56d)  Phase 2 (84d)  Phase 3 (12d) 
 
Torula Yeast
a  30.0 25.0 20.0 
Cottonseed Hulls  20.0  30.0  30.0 
Dextrose
b  10.0    4.0  --- 
Cornstarch
b 35.0  35.0  44.3 
Corn Oil
b    3.0    3.0    3.0 
Mineral/Vitamin 
Mix
c,d    2.0    2.0    1.7 
Urea  ---    1.0    1.0 
b International Ingredients Corporation, St. Louis, MO. 
c Contained the following in mg/kg diet: Ca, 150,000; P, 60,000; Na, 85,000; Mg, 25,000; K,  
  10,000; Co, 20; Cu, 2500; I, 200; Mn, 4,000; Zn, 6,000. 
d Contained the following per kg of diet: retinyl acetate, 136,079 IU; cholecalciferol, 13,608 IU;  
  α-tocopherol acetate, 136 IU.  
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Diets were analyzed for Se concentration by neutron activation at the University of 
Missouri-Columbia Research Reactor Center. Nine replicates were performed in the analysis of 
each sample so that the mean obtained from analysis did accurately reflect the Se concentration.  
Collection and Processing of Blood 
Blood was collected from each calf every 28 d beginning at 28 d of age. Approximately 
10 mL of blood were collected in 10 mL heparinized Vacutainer tubes (BD Vacutainer Systems, 
Franklin Lakes, NJ) via jugular venipuncture. Each blood sample was then centrifuged at 2,000 x 
g and 4° C for 10 min. Plasma was removed from each sample and placed into a labeled 5 mL 
Falcon
® tube (BD Biosciences, San Jose, CA) and stored at -80° C. The remaining packed 
erythrocytes were then washed in ice cold phosphate buffered saline and centrifuged 10 min at 
2,000 x g at 4° C for a total of three washes. Packed erythrocytes were then pipetted into 
individually labeled 1.5 mL microcentrifuge tubes and stored at -80° C. 
Measurement of Plasma GPx-3 Activity 
Because of the relatively quick turnover of plasma proteins and other cells, plasma GPx-3 
activity is an indicator of short-term Se status, providing a relatively quick picture of an animal’s 
immediate selenium condition (Gerloff, 1992). Plasma GPx-3 activity was determined using 
Glutathione Peroxidase Activity Assay Kits (Cayman Chemical Corporation, Ann Arbor, MI) 
and the ELx808 Absorbance Microplate Reader (BioTek Instruments, Inc., Winooski, VT). The 
Gen 5 data analysis software (BioTek Instruments, Inc., Winooski, VT) was used for data 
reduction and absorption analyses. Briefly, 100 µL of Assay Buffer (50 mM Tris-HCl, pH 7.6, 
containing 5 mM EDTA), 50 µL of Co-Substrate Mixture (a lyophilized powder consisting of 
NADPH, glutathione, and glutathione reductase), and 20 µL of sample plasma were pipetted, in 
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were also utilized: a blank, consisting of glass-filtered water, a negative enzyme control into 
which no glutathione peroxidase was added, and a positive control containing 20 µL of supplied 
purified bovine glutathione peroxidase. Each control was performed in triplicate within each 
plate that was analyzed in order to account for differences between plates. Each plate was 
incubated at 25° C and absorbance at 340 nm measured by the plate reader at time zero and then 
at one min intervals for 6 min, for a total of seven absorbance readings. GPx activity was 
calculated for each individual well by first determining the change in absorbance at 340 nm 
(Abs340) per min. Briefly, for each individual well, two points were selected on the linear portion 
of the resulting curve and the change in absorbance over that time period was calculated using 
the following equation: 
∆A340/min = (∆A340 @ Time 2 - ∆A340 @ Time 1) / Time 2 (min) – Time 1 (min), 
where ∆A340 was the absorbance at each respective time and Time 1 was the first chronological 
time in min and Time 2 was the second chronological time in min. The ∆A340/min was then also 
calculated for the non-enzymatic control wells and this rate subtracted from that of the sample 
wells. Activity was then determined using the NADPH extinction coefficient of 0.00373 µM
-1, 
which is the value adjusted for the 0.6 cm path length of the solution in the well from the actual 
value of 0.00622 µM
-1. Activity was calculated using the following formula: 
  GPx activity = ( |∆A340/min| / 0.00373 µM
-1) × (0.19 ml / 0.02 ml) = nmol/min/mL, 
where |∆A340/min| was the absolute value of the calculated absorbance at 340 nm per min and 
one enzyme unit was defined as the amount of enzyme that will cause the oxidation of 1 nmol 
NADPH per min.  
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was equivalent to the amount of GPx activity required to oxidize 1 µmol of NADPH per 1 min. 
Plasma protein concentrations were determined using the Quick Start Bradford Protein Assay Kit 
1 (Bio-Rad Laboratories, Inc,. Hercules, CA), an assay first described by Bradford (1976) in 
which the dye agent, Coomassie Brilliant Blue G-250 is used to bind solubilized protein. Plasma 
samples were diluted 1:50 in water before assaying. Briefly, a standard curve was constructed 
using 2 mg/mL bovine serum albumin (BSA) in which seven concentrations ranging from 0 
µg/mL BSA to 2000 µg/mL BSA were used. Standards were analyzed in triplicate. Samples 
were then diluted 1:50 using glass-filtered H2O and 20 µL were pipetted into each of two 
disposable cuvettes (Bio-Rad Laboratories, Inc,. Hercules, CA). To initiate the reaction, 1 mL of 
Coomassie Brilliant Blue (Bio-Rad Laboratories, Inc,. Hercules, CA) was added to each cuvette 
and allowed to incubate for 5 min after gentle inversion. Absorbance was measured at 595 nm 
using the Smart Spec Plus Spectrophotometer (Bio-Rad Laboratories, Inc., Hercules, CA) and 
concentrations were calculated using the previously constructed standard curve. Thus, using 
protein concentrations, all GPx activities were expressed per g protein.  
Measurement of Cytosolic GPx-1 Activity in Erythrocytes 
  Due to the slow turnover of erythrocytes, with which 98% of GPx activity is associated 
(Scholtz and Hutchinson, 1979), and the fact that GPx-1 is incorporated into erythrocytes during 
erythropoiesis, GPx-1 activity in erythrocytes is considered an indicator of long-term Se status 
(Gerloff, 1992). Cytosolic GPx-1 activity was determined using Glutathione Peroxidase Activity 
Assay Kits (Cayman Chemical Corporation, Ann Arbor, MI) and the ELx808 Absorbance 
Microplate Reader (BioTek Instruments, Inc., Winooski, VT), as previously described. Thawed 
erythrocytes were then lysed in ice-cold glass-filtered water to a 1:4 dilution, followed by 1:100 
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mg/mL BSA). The assay procedure and activity calculations were the same as previously 
described for determination of Plasma GPx-3 activity. 
 Erythrocyte  GPx-1  activities  were expressed as enzyme units per gram of hemoglobin, 
where 1 EU was equivalent to the amount of GPx activity required to oxidize 1 µmol of NADPH 
per 1 min. Hemoglobin was measured using Quantichrom
TM Hemoglobin Assay Kits (BioAssay 
Systems, Hayward, CA). Briefly, blank and standard wells were made in triplicate for each plate 
performed by pipetting 50 µL of water for the standards and 50 µL of provided standard solution 
containing 100 mg/dL hemoglobin in 0.02% tartrazine, followed by the addition of 200 µL water 
into each of three wells. Blood samples were first diluted 100 fold in ice-cold distilled water. 
Samples were analyzed in duplicate by pipetting 50 µL of sample into each of two wells, 
followed by 200 µL of Reagent (0.40% sodium hydroxide and 2.60% Triton X-100), provided in 
the kit. Plates were then incubated for 5 min at approximately 27º C. Absorbance at 400 nm was 
then read using a Power Wave Microplate Spectrophotometer (BioTek Instruments, Inc., 
Winooski, VT). Absorbance data were collected by the Gen5 Software System (BioTek 
Instruments, Inc., Winooski, VT). Hemoglobin concentration (mg/dL) was calculated with the 
following equation: 
(Abs400 sample – Abs400 blank / Abs400 standard – Abs400 blank) * 100 * n, 
where “n” was the dilution factor. 
Measurement of Cytosolic GPx-1 Activity in Liver Tissue 
   Cytosolic GPx-1 in liver tissue was again determined using Glutathione Peroxidase 
Activity Assay Kits (Cayman Chemical Corporation, Ann Arbor, MI) and the ELx808 
Absorbance Microplate Reader (BioTek Instruments, Inc., Winooski, VT). Liver tissue collected 
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liquid nitrogen was used to determine GPx-1 activity. Briefly, approximately 1g of each liver 
sample was individually ground under liquid nitrogen with a frozen mortar and pestle without 
allowing the samples to thaw. The finely ground sample was then placed into a 14 mL Falcon
® 
tube (BD Biosciences, San Jose, CA) and 10 mL of cold buffer (50 nM Tris-HCl (pH 7.5), 5 mM 
EDTA, and 1 mM DTT) were added to the sample and mixed thoroughly. The samples were then 
each centrifuged at 10,000 x g for 15 min at 4° C and the supernatant removed and stored at  -80° 
C for no longer than one month. Hemolysate dilutions of 1:400 were prepared using sample 
buffer (50 mM Tris-HCl, pH 7.6, containing 5 mM EDTA and 1 mg/mL BSA). The liver 
hemolysate was then used to determine liver GPx-1 activity using the Cayman Chemical 
Glutathione Peroxidase Activity kit (Cayman Chemical Corporation, Ann Arbor, MI), but with 
some minor modifications. Briefly, 70 µL of Assay Buffer (50 mM Tris-HCl, pH 7.6, containing 
5 mM EDTA), 50 µL of Co-Substrate Mixture (a lyophilized powder consisting of NADPH, 
glutathione, and glutathione reductase), 20 µL Double Strength Drabkin’s Reagent (Potassium 
cyanide/Potassium ferricyanide), 10 µL 0.01 M NaN3, and 20 µL of sample hemolysate were 
pipetted, in triplicate per sample, into a 96 well plate placed on ice, for a total per well volume of 
170 µL. Four controls were also utilized: a blank, consisting of glass-filtered water, a blank 
consisting only of reagent and to which no hydrogen peroxide was added, a negative enzyme 
control into which no glutathione peroxidase was added, and a positive control containing 20 µL 
of supplied purified bovine glutathione peroxidase. Each control was performed in triplicate 
within each plate that was analyzed in order to account for differences between plates. To initiate 
the reaction, 20 µL of 12 mM H2O2 was pipetted into each well used and then the plate was 
incubated at 25° C and absorbance at 340 nm measured by the plate reader at time zero and then 
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were then calculated as outlined for GPx-3. GPx-1 activity in liver tissue was expressed as 
enzyme units per gram protein, and tissue protein concentrations were determined on 1:10 
dilutions of liver tissue hemolysate in water using the Quick Start Bradford Protein Assay Kit 1 
(Bio-Rad Laboratories, Inc., Hercules, CA) as previously described. 
Measurement of Liver Tissue Se Concentration 
Liver tissue Se concentration was determined via the method of Martin and Williams 
(1989), with some changes. Briefly, liver samples were dried at 60º C in a drying oven and 
weighed every 12 h for 36 h until completely dry. Approximately 0.5 g of tissue from each 
sample was weighed in duplicate into Teflon
® microwave tubes and 4 mL of 70% HNO3 were 
added to each tube. Samples were allowed to pre-digest for 12 h before digestion. Liver samples 
were then digested in a MARS5 microwave digester (CEM Corporation, Matthews, NC) at 1,200 
watts on maximum power with a 15 min ramp time followed by 15 min of digestion at 200º C.  
After cooling, digested samples were brought to 10 mL total volume with deionized, 
distilled water and stored in 14 mL polystyrene Falcon
® tubes (BD Biosciences, San Jose, CA) 
until processing. Selenium concentration was determined by the method of GFAAS using a 
Perkin Elmer Zeeman 5100 Graphite Furnace Spectrophotometer (Perkin Elmer Life and 
Analytical Sciences, Inc., Waltham, MA) at 196 nm.  
Isolation of mRNA from Liver Tissue 
Total mRNA was isolated from frozen liver tissue using the Dynabeads
® mRNA 
DIRECT Isolation Kit (Dynal Biotech, Inc., Lake Success, NY, USA). Approximately 30 to 50 
mg of frozen liver tissue stored at -80º C was ground in liquid nitrogen using an autoclaved 
mortar and pestle frozen in liquid nitrogen. The tissue was not allowed to thaw at any time before 
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mm EDTA, 1% lithium dodecylsulfate, and 5 mM dithiothreitol) to the sample. The sample was 
then homogenized for 3 to 5 min in the lysis/binding buffer using a pair of autoclaved hemostatic 
forceps previously wiped with RNase Away (Molecular Bio-Products, Inc., San Diego, CA). The 
lysed sample was then forcibly passed 3 to 5 times through a 21 gauge needle using a 3 cc sterile 
syringe in order to shear the DNA. After centrifuging the sample for 60 s, the supernatant was 
removed and added to 250 µL of pre-washed Dynabeads Oligo (dT)25. The sample and beads 
were allowed to hybridize for 5 min with continuous mixing in a roller mixer in order to give the 
mRNA poly-A tail time to anneal to the Dynabead (dT)25. The microcentrifuge tube containing 
the mixture was then placed onto the Dynal MPC-E-1 magnetic separator for 2 min and the 
resulting supernatant discarded. The remaining beads-mRNA complex was then washed twice in 
1 mL of washing buffer A (10 mM Tris-HCl, pH 8.0, 150 mM LiCl, 1 mM EDTA, and 0.1% 
lithium dodecylsulfate) followed by a single wash in 1 mL of washing buffer B (10 mM Tris-
HCl, pH 8.0, 150 mM LiCl, and 1 mM EDTA). The beads-mRNA complex was then washed in a 
additional 40 µL of washing buffer B. After discarding washing buffer B, the mRNA was eluted 
by adding 25 µL of 10 mM Tris-HCl to the beads-mRNA complex and incubation for 2 min in a 
75º C water bath. The microcentrifuge tube containing the eluted RNA and beads was then 
placed immediately onto the magnet and the free mRNA was removed and added to a labeled 
nuclease-free 0.5 mL centrifuge tube. The mRNA was then kept on ice for immediate cDNA 
synthesis. 
Reverse Transcriptase cDNA Synthesis 
  Complementary DNA (cDNA) was synthesized using the iScript cDNA Synthesis Kit 
(Bio-Rad Laboratories, Inc., Hercules, CA). Briefly, 12.5 µL of isolated template mRNA was 
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transcriptase in a PCR tube for a total volume of 20 µL. A no reverse transcriptase control 
reaction containing 12.5 µL isolated template mRNA, 4 µL 5x iScript reaction mix, 2.4 µL 
nuclease-free water and 1 µL autoclaved water was also performed. Reverse transcriptase PCR 
(RT-PCR) was performed using an iCycler ThermalCycler (Bio-Rad Laboratories, Inc., 
Hercules, CA) at 25º C for 5 min, 42º C for 30 min, and a 5 min denaturing step at 85º C with a 
final hold temperature of 4º C.  
Primer Design for PCR Amplification  
Primers for PCR amplification of GPx-1 cDNA were designed based on a published 
bovine nucleotide sequence (Mullenbach et al., 1988; GenBank Accession No. X13684, 828 
nucleotides) using the Beacon Designer 4.0 software program (PREMIER Biosoft International). 
Primers for PCR amplification of Poly-A polymerase cDNA were based on a published bovine 
nucleotide sequence (Raabe et al., 1991; GenBank Accession No.X63436, 3431 nucleotides). 
Primers were synthesized by Life Technologies (Invitrogen, Carlsbad, CA) (Table 3.2).  
Table 3.2. Primers for amplification of GPx-1 and Poly-A cDNA.  
Gene  Accession 
Number  Primer Sequence  Amplicon 
Length (bp)
Poly-A X63436  Sense AAGCAACTCCATCAACTACTG 
Antisense  ACGGACTGGTCTTCATAGC  169
GPx-1 X13684  Sense AACGCCAAGAACGAGGAG 
Antisense GGACCAGGTGATGAACTTAGG  204
 
Validation of Primers and RNA Isolation 
  Based on previous work (Wrenzycki, 1998), Poly-A polymerase (Poly-A) was chosen as 
an internal control gene for this experiment, as its expression and abundance are unaffected by 
Se status (Lei et al., 1995). The primers for this gene and GPx were validated by performing a 
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tissue samples taken from the three BSL calves slaughtered at 21 d of age. Each reaction 
contained 5µL of 10x PCR buffer, 1 µL dNTP (10 µL dGTP, 10 µL dCTP, 10 µL dATP, 10 µL 
dTTP, and 60 µL autoclaved water), 1µL forward primer (either GPx or Poly-A), 1µL reverse 
primer (either GPx or Poly-A), 39µL autoclaved water, 1µL template cDNA, and 2 µL 
Jumpstart
™ REDTaq™ DNA Polymerase (Sigma, Saint Louis, MO) for a total reaction volume 
of 50µL. A working master mix for each primer set was first made, consisting of all reaction 
components with the exception of the template cDNA. This mix was then pipetted into 
individual PCR tubes and 1µL cDNA added to each PCR tube for a total reaction volume of 50 
µL. Amplification was performed in the iCycler Thermalcycler (Bio-Rad Laboratories, Inc., 
Hercules, CA) with a 95° C initial denaturing step for 1 min, 35 cycles of 30 s denaturation at 
95° C, 30 s annealing at 56° C, and 30 s extension at 72° C, followed by a 4 m final extension at 
72° C and a final hold temperature of 4° C. Gel electrophoresis was then performed by loading 
25 µL of each sample into individual wells of a 2% agarose gel. A 100 bp ladder added to the 
same gel was used to confirm the size of the resulting amplicon for each gene of interest. The 
presence of GPx mRNA in all isolated samples was then confirmed using the same protocol as 
discussed previously (Figure 3.1). 
Optimization and Validation of Quantitative Real Time PCR (Q-PCR) 
Optimization of primer conditions is a necessary part of ensuring that primers amplify 
only target cDNA during PCR. Primer annealing temperature was optimized by utilizing an 
annealing temperature gradient consisting of five temperatures from 50° C to 65° C. Gel 
electrophoresis in a 2% agarose gel was then used to determine the best annealing temperature 
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apparent quantity   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Gel of bovine GPx cDNA in samples and individual baseline calves. The no reverse 
transcriptase controls are located in the lane to the right of each sample. The 100 bp ladder is in 
the first well, to the left of samples in all three gels. 
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Figure 3.2. Gel of annealing temperature gradient. The amplicon obtained by annealing at 56º C 
is the fourth well from the bottom of the gel. The first well is a 100 bp ladder. 
 
of amplicon as determined by relative band brightness when electrophoresed and placed into a 
Gel Dock Eq (Bio-Rad Laboratories, Inc., Hercules, CA) for viewing under ultraviolet light 
(Figure 3.2).  
In order to ensure that the chosen primers were indeed quantitative in amplification, ten-
fold dilution series were performed with the calibrator, an equal mix of cDNA from the three 
BSL calves. Both Poly-A and GPx-1 primers were validated in this manner in separate reactions. 
Ten-fold dilutions were prepared by first adding 2 µL of undiluted calibrator cDNA to 18 µL of 
autoclaved water, making a 1:10 dilution. From this dilution, 1:100, 1:1000, and 1:10,000 
dilutions were made. In addition, a “no template control” consisting of only autoclaved water and 
lacking any template cDNA was also made and utilized to ensure that there was no 
DNAcontamination of the reaction. Each reaction consisted of 12.5 µL of SYBR Green (Bio-Rad 
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anti-sense primer for the gene to be amplified, 9.5 µL of autoclaved water, and 1µL of cDNA 
from one of the dilutions for a total reaction volume of 25 µL. A master mix containing all 
reactants with exception of template cDNA and dilutions was first made and 96 µL of said 
master mix was pipetted into six 0.5 µL microcentrifuge tubes. Into each tube was then pipetted 
4 µL of one of the dilutions. The no template control reaction tube received 4 µL of autoclaved 
water. The contents of each tube were then pipetted in triplicate into half of a 96-well plate, for a 
total volume of 25 µL per well. The plate was then placed into an iCycler thermal cycler (Bio-
Rad Laboratories, Inc., Hercules, CA) and a two-step amplification was performed with an initial 
denaturation step for 3 min at 95° C for 1 cycle, followed by 40 cycles of a two step process 
consisting of denaturation for 10 s at 95° C and annealing for 45 s at 56° C. Florescence was 
measured during this time and real-time analysis performed using the My iQ software system 
(Bio-Rad Laboratories, Inc., Hercules, CA). This was followed by 1 cycle of denaturation at 95° 
C for 1 min, one cycle of annealing at 56° C for 1 min, and 80 cycles at 55° C. After cycle 2 at 
55° C, the temperature was increased by 0.5° C intervals and melt curve data collected for the 
duration of the cycles. A final hold temperature of 10° C was then maintained. From each 
analysis a standard curve, melt curve, and dilution Ct values of the ten-fold dilutions were 
created and the efficiency and correlation coefficient provided by the My iQ Reverse 
Transcription PCR Detection software system (Bio-Rad Laboratories, Inc., Hercules, CA) 
(Figure 3.3). All of the target genes in both the samples and calibrator had efficiencies between 
80 and 120%, which is the range considered acceptable for quantitative PCR. Correlation 
coefficients for all target genes were also acceptable, being as close to 1.0 as possible.  
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    Real time PCR was performed to measure the relative amount of GPx, the gene of 
interest, and Poly-A polymerase, the internal control, mRNA in each of the eight liver samples 
and the calibrator. Each reaction consisted of 12.5 µL SYBR Green (Bio-Rad Laboratories, Inc., 
Hercules, CA), 1 µL of sense primer for the gene to be amplified, 1 µL antisense primer for the 
gene to be amplified, 9.5µL autoclaved H2O, and 1µL of the cDNA to be amplified for a final 
reaction volume of 25 µL per well. Two master mixes were made containing all reactants with 
exception of template cDNA, one for each gene of interest, and Q-PCR was performed for both 
genes in all samples, including the calibrator. Again, a “no template control” consisting of only 
autoclaved water and lacking any template cDNA was also made for both GPx and Poly-A, 
which was utilized to ensure that there was no DNA contamination of the reaction. Into each of 
ten 0.5 µL microcentrifuge tubes per gene of interest was pipetted 96µL of master mix, followed 
by 4µL of sample cDNA, one sample per microcentrifuge tube per gene. The no template 
controls each received 4 µL of autoclaved water. The contents of each tube were then pipetted in 
triplicate into a 96-well plate, for a total volume of 25 µL per well. The plate was placed into the 
MyIQ ThermalCycler (Bio-Rad Laboratories, Inc., Hercules, CA) and a two-step amplification 
was performed, as previously discussed in the validation of the Q-PCR reaction.  
SYBR Green fluorescence was detected by the MyIQ Reverse Transcription PCR Detection 
System (Bio-Rad Laboratories, Inc., Hercules, CA). Data were used to calculate the quantity of 
mRNA based on the method for relative quantification in Q-PCR based on previous work by 
Pfaffl (2001), in which quantities of mRNA are expressed as n-fold differences relative to a 
calibrator. The calibrator used for this experiment consisted of cDNA from the combined liver  
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Figure 3.3.  Dilution Ct values, melting curves, and standard curve obtained with primers 
for GPx-1 amplification in calibrator sample. Five 10-fold dilutions (undiluted, 1:10, 
1:100, 1:1000, and 1:10,000) of calibrator cDNA were used for the generation of (A) 
dilution Ct values, (B) melting curves, and (C) a standard curve. 
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on a Se-adequate or Se-deficient diet. 
Poly-A polymerase was used as the reference gene for all samples, including the calibrator. 
Relative transcription values were then calculated by first using the threshold cycle (CT) values  
of the reference gene to normalize the target gene signals for each sample, resulting in the ΔCTT 
for the target gene and the ΔCTR for the reference gene. The ΔCTT was calculated by subtracting 
the CT value for the target gene in the calibrator from the CT value for the target gene in each 
sample. Likewise, the ΔCTR was calculated by subtracting the CT value for the reference gene in 
the calibrator from that of the reference gene in each sample. The amount of target gene 
amplicon relative to the calibrator was then calculated using the following formula: 
n-fold difference = Efficiency Target Gene
ΔCTT / Efficiency Reference Gene
ΔCTR . 
As a result, all mRNA quantities were expressed as the n-fold difference related to the calibrator, 
normalized to the reference gene. 
Statistical Analysis 
  Statistical analyses were performed on all data to determine statistical significance. 
Response variables of interest were average daily gain (ADG), average daily intake (ADI), liver 
tissue Se concentration, RBC-GPx activity, GPx-3 activity, liver GPx-1 mRNA, and relative 
liver GPx-1 mRNA n-fold difference. Calf was considered the experimental unit for all analyses 
and significance was determined at the 0.05 level. Calf ADG, ADI, RBC-GPx activity, and GPx-
3 activity were considered to be repeated measures and were analyzed using the Proc Mixed 
procedure in SAS (SAS Institute, Cary, SC). Liver tissue Se concentrations, liver GPx-1 activity, 
and relative liver mRNA data were treated as a completely randomized ANOVA and were 
analyzed using the Proc Mixed procedure of SAS (SAS Institute, Cary, SC). Regression and 
correlation analyses were performed on relative mRNA levels, RBC-GPx activity, and GPx-3 
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respectively.  
Results and Discussion 
Growth and Intake 
Supplemental Se inclusion had no effect on ADI at any time during the experiment. The 
mean ADI for diet phase 1, which occurred from 28 d of age until 83 d of age, was 1.86 ± 0.07 
kg/d. During phase 2, which lasted from 84 d of age until 167 d of age, the mean ADI was 2.88 ± 
0.07 kg/d. Average daily intake during phase 3, which lasted from 168 d until trial completion at 
180 d of age, was 3.30 ± 0.08 kg/d (Figure 3.4).  
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Figure 3.4. Average daily intake (kg/d) by phase for calves fed diets supplemented or 
unsupplemented with Se.  
 
Likewise, growth was unaffected by dietary treatment (Figure 3.5), which was in agreement with 
findings in previous research in swine, cattle, and poultry (Mahan and Parrett, 1996; Lawler et 
  53al., 2004; Payne and Southern, 2005). The ADG during phase 1 was 0.65 ± 0.097 kg/d. Average 
daily gain during phase 2 was 0.69 ± 0.097 kg/d, while phase 3 ADG was 0.53 ± 0.110 kg/d. 
Liver Se Concentration 
Liver Se concentration at d 180 of age for baseline calves and calves maintained on the 
Se adequate diet were significantly higher than that of calves maintained on the Se-deficient diet, 
but liver Se concentration was not different between baseline calves and calves maintained on 
the Se-adequate diet. Mean Se concentration in the livers of baseline calves and those maintained  
on the Se-adequate diet were 0.800 ± 0.105 ppm and 0.742 ± 0.091 ppm, respectively (dry 
weight). Mean Se concentration in the livers of calves maintained on the Se-deficient diet was 
0.412 ± 0.091 ppm (dry weight) (Figure 3.6).  
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Figure 3.5. Average daily gain (kg/d) by phase for calves fed diets supplemented or  
unsupplemented with Se. 
 
The mean liver Se concentration of  calves fed the Se-deficient diet was higher than that 
reported in 8 wk old lambs by Oh et al. (1976), in which lambs fed a torula yeast-based milk diet 
  54containing 0.01 ppm Se had an average liver Se concentration of 0.049 ppm Se on a wet basis, 
but the mean liver Se concentrations of calves fed the Se adequate diet were similar to lambs fed 
the torula-based milk diet supplemented with 0.10 ppm Se. Lambs supplemented with 0.10 ppm 
Se were reported as having an average liver Se concentration of 0.183 ppm Se on a wet basis. 
Although Se concentration is generally considered to be higher in muscle tissue (Behne 
and Wolters, 1983), the concentration of Se in the liver is of considerable importance, as it is 
reflective of Se status (Abdelrahman and Kincaid, 1995). This is demonstrated by the 1 
comparison of the distribution of Se concentration in various tissues and the distribution of GPx-
activity in those same tissues. While muscle and liver tissue have been reported to contain 
approximately 39.8 and 31.7% of the Se found in the body respectively, only 6.1 % of GPx-1 
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Figure 3.6. Mean liver Se concentration by treatment at d 180 of age. 
 
activity is located within muscle tissue while 65.6 % of GPx-1 activity is located in liver tissue 
(Behne and Wolters, 1983). The liver Se concentration of the sampled calves at d 180 of age 
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  55followed the expected trend: calves maintained on the Se adequate diet had, on average, almost 
50% higher liver Se concentrations than that of calves maintained on the Se-deficient diet. This 
was in agreement with the findings of previous research in which mammals of various species 
maintained on Se-deficient diets were shown to have significantly decreased concentrations of 
liver Se when compared to that of animals fed a diet adequate in Se (Mahan et al., 1999; Payne 
and Southern, 2005; Hostetler et al., 2006). However, the Se concentration of Se adequate and 
deficient treatment groups were lower than the expected range noted by Stowe and Herdt (1992), 
in which they report the normal liver Se concentration of all species, regardless of age, should be 
in the range of 1.2 to 2.0 ppm Se on a dry weight basis. The liver Se concentrations in both Se 
adequate and Se-deficient calves were also lower than values reported by Abdelrahman and 
Kincaid (1995) in which 42 d old calves born to dams either supplemented with Se via a Se bolus 
or unsupplemented with Se had a mean liver Se concentration of 2.62 and 1.20 ppm Se on a dry 
weight basis, respectively.  
Glutathione Peroxidase-3 and Glutathione Peroxidase-1 Activities 
  Plasma GPx-3 activity varied considerably between sampling times throughout the 
duration of the trial for both treatment groups, but a significant difference (P < 0.05) between 
treatments was not detected until d 180 of age. At this time a decrease of approximately 52% in 
GPx-3 activity in the Se-deficient group was observed (1.79 ± 0.20 versus 0.86 ± 0.16 EU/g 
protein) (Figure 3.7).   
The RBC-GPx activity was more reflective of the Se content when compared to GPx-3 
activity. While treatment differences in GPx-3 activity were observed on d 180 of age, calves 
supplemented with Se had higher RBC-GPx activity at d 84 of age and through trial termination 
(P < 0.01). On d 84 of age the mean RBC-GPx activity of calves maintained on the Se adequate 
diet was 52.09 ± 4.61 EU/g Hb, while the mean RBC-GPx activity for calves fed the Se-deficient 
  56diet was 24.47 ± 4.61 EU/g Hb. This represented approximately a 61% decrease in RBC-GPx 
activity in those calves maintained on the Se-deficient diet. By d 180 of age the mean RBC-GPx 
activity of Se-adequate and Se-deficient calves was 54.98 ± 6.20 and 11.56 ± 4.95 EU/g Hb, 
respectively, representing a 79% decrease in GPx-1 activity in calves maintained on the Se-
deficient diet (Figure 3.8). 
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Figure 3.7. Mean GPx-3 activity of Se supplemented and unsupplemented calves by  
day.  
 
As previously discussed, GPx-3 activity is generally considered to be an indicator of 
short term Se status. Therefore, the considerable variation observed with respect to the trend in 
GPx-3 activity for both groups was expected, as day to day feed intake and hydration status may 
have played a role in affecting GPx-3 activity measurements. In addition, Oh et al. (1976) 
reported that unlike circulating plasma Se, erythrocytes contain a relatively constant proportion 
of total blood Se. However, it was surprising that no detectable decrease in GPx-3 activity 
  57occurred before d 180 of age, when the first significant decrease in RBC-GPx activity for calves 
maintained on the Se-deficient diet was observed by d 84 of age. Erythrocyte GPx-1 activity was 
not expected to differ significantly until calves were older, based on the 90 to 120 d whole body 
turnover of erythrocytes (Gerloff, 1992); likewise, GPx-3 activity was expected to decrease in Se  
deficient calves at an earlier time point than observed. However, the seemingly early decrease in  
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Figure 3.8. Mean erythrocyte GPx-1 activity of Se supplemented and unsupplemented  
calves by day. 
 
RBC-GPx activity may be explained by considering that RBC-GPx is incorporated into
 
erythrocytes during erythropoiesis (Gerloff, 1992). The time at which the first difference in 
RBC-GPx activity was observed between treatments actually approximates the half-life of 
bovine erythrocytes (Oh et al., 1976; Gerloff, 1992) and RBC-GPx activities were analyzed as a 
mean of all calves within a treatment group.  In addition, the considerable variation observed 
with respect to GPx-3 activity may also be explained as a function of the fact that GPx-3 is 
  58considered a short-term indicator of Se status (Gerloff, 1992). Although calves were limit-fed 
with regard to the amount of ration they received at each feeding, they were not limited in the 
amount of time allowed to consume the ration. Not all calves were observed to eat at the same 
rate; it is possible that calves consuming the ration slowly throughout the day might have 
maintained higher, more consistent plasma Se levels and therefore higher GPx-3 activity levels if 
sampled shortly after consuming feed, affecting the overall trend in GPx-3 activity. 
  Plasma GPx activity for both treatment groups was in agreement with GPx-3 activities 
previously reported by Rowntree et al. (2004) in beef cows, in which cows either receiving no 
supplemental Se or a 20 mg Se drench per day had an average GPx-3 activity of 0.92 and 1.34 
EU/g protein, respectively. The decrease in GPx-3 activity observed in calves maintained on the 
Se-deficient diet were in agreement with previous reports in various species in which animals 
were fed either a diet adequate or deficient in Se, although the actual amounts of GPx-3 activity 
varied considerably from species to species (Weiss et al., 1996; Lei et al., 1998; Enjalbert, 1999; 
Mahan et al., 1999).   
The trend observed in RBC-GPx activity occurred as expected, with Se adequate calves 
maintaining a relatively constant RBC-GPx activity while the RBC-GPx activity of Se-deficient 
calves decreased over time. The RBC-GPx activity for both treatment groups supported previous 
research in which animals maintained on a Se-deficient diet were reported to have significantly 
decreased RBC-GPx activity levels when compared to animals of the same species maintained 
on a Se adequate diet. Oh et al. (1976) reported that lambs maintained on a Se-deficient artificial 
milk diet had RBC-GPx activity levels that were significantly decreased (P < 0.01) when 
compared to that of lambs maintained on a diet supplemented with 0.1 ppm Se. Weiss et al. 
(1996) reported that female rats maintained on a Se-deficient basal diet containing 0.007 ppm Se 
had an average RBC-GPx activity that was only 40% of the activity observed in rats maintained 
  59on the basal diet supplemented with 0.1 ppm Se as sodium selenite. Rowntree et al. (2004) 
reported that pregnant beef cows either unsupplemented with Se or supplemented with a 20 mg 
Se drench had RBC-GPx activity levels of 14.94 EU/g Hb and 24.61 EU/g Hb, respectively, 
although these activities were actually somewhat lower than those found in our research using 
neonatal Holstein calves.     
Liver GPx-1 activity on d 180 of age was not affected by dietary treatment (P= 0.581). 
The average liver GPx-1 activities for Se adequate and Se-deficient groups were 2079.33 ± 
943.20 and 2553.13 ± 816.84 EU/g protein, respectively, while that of the baseline calves was 
3241.25 ± 943.2 EU/g protein (Figure 3.9). The liver GPx-1 activity of both the Se adequate and 
baseline groups was a mean of the activities from three calves, while the activity of the Se-
deficient group was the mean of four calves. A calf in the Se adequate group was removed from 
the analysis as it was determined to be an outlier.  
These findings are not in agreement with any literature currently available. Oh et al. 
(1976) reported a significant increase (P < 0.01) in the liver tissue GPx-1 activity of 8 wk old 
lambs fed a torula yeast-based artificial milk diet supplemented with either 0.05 or 0.1 ppm Se, 
versus lambs fed the same diet unsupplemented with Se. Likewise, Whanger and Butler (1988) 
reported that rats fed a Se-deficient basal diet containing 0.02 ppm Se had an average liver GPx-
1 activity of 8 ± 4 EU/g protein, representing 1.1% of the activity observed in rats maintained on 
the basal diet supplemented with 0.2 ppm Se as sodium selenite. Furthermore, Weiss et al. 
(1996). reported female rats maintained on a basal diet containing 0.007 ppm Se had an average 
liver GPx-1 activity that was only 2 ± 1% of the activity observed in female rats maintained on 
the basal diet supplemented with 0.1 ppm Se as sodium selenite. It was considered that perhaps 
the liver GPx-1 activity response in larger mammals was not as profound as that observed in rats, 
but Lei et al. (1998) reported that pigs fed a diet containing 0.03 ppm Se had an average liver 
  60GPx-1 activity of 12.5 EU/g protein, whereas pigs maintained on the basal diet supplemented 
with 0.3 ppm Se had an average liver GPx-1 activity of 210 EU/g protein, representing a 94% 
decrease in liver GPx-1 activity in pigs fed the Se-deficient diet.  
 
 
 
 
 
 
 
 
 
 
a EU= enzyme unit; 1 EU is the amount of GPx activity required to oxidize 1 µmol 
NADPH per min. 
 
Figure 3.9. Mean liver GPx-1 activity of 21 d old baseline calves, and Se supplemented, 
and Se unsupplemented calves on d 180 of age. 
 
Glutathione S-transferase (GST; EC 2.5.2.18) activity was considered as a possible 
explanation for the unexpected results obtained in this study. Glutathione S-transferase is a Se-
independent glutathione peroxidase (Burk, 1983) associated with the reduction of certain organic 
hydroperoxides (Ullrey, 1987). These GST enzymes have been reported to be most active in 
tissues such as brain, liver, kidneys, adrenals, and testes, while tissues such as spleen, muscle, 
lungs, erythrocytes, thymus, and plasma have relatively little or no GST activity associated with 
them (Behne and Wolters, 1983). Research has shown that the use of organic hydroperoxides 
such as cumene hydroperoxide in the assay of GPx-1 activity in some tissues may result in 
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  61falsely elevated GPx-1 activity levels, especially in tissues of animals maintained on Se-deficient 
diets (Lawrenece and Burk, 1976). In fact, Lei et al. (1998) reported that GST activity for pigs 
fed a Se-deficient basal diet containing 0.03 ppm Se or the basal diet supplemented with either 
0.1 or 0.3 ppm Se as sodium selenite had liver GST activities of 513.4, 448.9, and 264.6 nmol S-
2,4-dinitrophenylglutathione per min per mg protein, respectively. This finding supported 
previous research in which it was determined that GST activity was induced by Se deficiency 
(Christensen et al., 1994; Cheng et al., 1997). However, GST cannot catalyze the reduction of 
H2O2. For this reason, when liver GPx-1 activity assays were performed for this experiment, 
H2O2 was used as the substrate in order to eliminate the accidental assay of GST and 
overestimation GPx-1 activity. Catalase, an iron-requiring peroxidase enzyme, could have 
contributed to the overestimation of GPx-1 activity in the liver samples from Se-deficient calves. 
However, two catalase inhibitors, sodium azide (NaN3) and cyanide contained in Drabkin’s 
Reagent, were thus added to the reaction to inhibit the activity of this enzyme. 
Most likely, the small sample size of calves euthanized for collection of liver samples 
played a part in both the unusually high standard error of the mean and the unexpected results 
observed regarding liver GPx-1 activity. In addition, calves were only sampled once, at trial 
termination, due to the large amount of tissue required for determination of liver Se 
concentration, liver GPx-1 activity, and liver GPx-1 mRNA relative transcript level analysis. We 
hypothesize that sampling of calves for liver samples at 28 d intervals, as was performed in the 
collection of blood and plasma, may be beneficial in obtaining a more realistic picture of liver 
GPx-1 activity over time. This might be accomplished in the future by performing liver biopsies 
for collection of liver tissue at pre-determined intervals in lieu of euthanizing calves. 
 
 
  62Liver GPx-1 mRNA Transcript Levels 
  Relative liver GPx-1 mRNA transcript level on d 180 of age was significantly higher (P< 
0.05) for the Se adequate group. On average, Se adequate calves had a relative mRNA level that 
was approximately 30% greater than the level of mRNA expression in baseline calves, while Se-
deficient calves had approximately a 45% decrease in average relative mRNA level when  
compared to that of baseline calves. The difference in mRNA transcript level of the Se adequate 
treatment group versus the Se-deficient treatment group was considered to be significant. (Figure 
3.10). 
 These observations are in agreement with previous research examining the effect of Se 
deficiency on relative liver GPx-1 transcript levels, although the extent to which the GPx-1 
mRNA levels decreased varied among species. Weiss et al. (1996) reported that GPx-1 mRNA  
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   Different letters denote significant difference (P < 0.05). 
Figure 3.10. Relative GPx-1 mRNA transcript levels of baseline, Se supplemented, and 
a,b
Se unsupplemented calves expressed as n-fold differences. 
 
  63levels normalized to 18S rRNA of female rats fed a basal diet containing 0.007 ppm Se were 17 
± 4% of those found in rats fed the basal diet supplemented with 0.1 ppm Se. Lei et al. (1998) 
determined that liver GPx-1 mRNA levels of pigs fed a Se-deficient basal diet containing 0.03 
ppm Se were significantly lower (P< 0.05) than that of pigs maintained on the basal diet 
supplemented with 0.1 or 0.3 ppm Se as sodium selenite. However, these findings are not in 
agreement with those of Hostetler et al. (2006), in which sows fed a Se-deficient diet containing 
0.05 ppm were found to have no significant decrease (P > 0.05) in liver GPx-1 mRNA level 
when compared to sows consuming a diet containing 0.39 ppm Se. Based on these results, calves 
in our study maintained on the Se-deficient diet may not have achieved severe Se deficiency. To 
our knowledge this is the first report of the effect of Se deficiency on relative liver GPx-1 mRNA 
transcript levels in the bovine. 
Regression analyses were performed to determine the relationship between GPx-1 mRNA 
transcript level and both RBC-GPx and GPx-3 activity. There was a positive linear relationship 
between liver GPx-1 mRNA n-fold difference and RBC-GPx activity (Adjusted r
2= 0.47; r
2= 
0.58; Figure 3.11). There was also a positive linear relationship between GPx-1 mRNA n-fold 
difference and GPx-3 activity (Adjusted r
2= 0.76; r
2= 0.81; Figure 3.12).  
Correlation analyses were also performed to determine the extent of the relationship 
between the variables in each of the regression analyses. Erythrocyte GPx-1 activity and GPx-1 
mRNA n-fold difference were moderately correlated, with a Pearson’s Correlation Coefficient of 
0.70. Interestingly, GPx-3 activity and GPx-1 mRNA n-fold difference were highly correlated, 
with a Pearson’s Correlation Coefficient of 0.90.  
The positive linear relationship observed between liver GPx-1 mRNA levels and both 
RBC-GPx and GPx-3 were expected, as GPx mRNA transcript level is expected to increase 
sigmoidally in response to Se supplementation (Weiss et al., 1996), while both RBC-GPx and 
  64GPx-3 activities increase with increasing Se supplementation until reaching a specific plateau 
point (Weiss et al., 1996; Lei et al., 1998). However, the strength of both the linear relationship 
and the correlation coefficient for GPx-1 to GPx-1 mRNA levels was unexpected, as these were 
higher for GPx-3 than they were for RBC-GPx. It is currently unclear as to whether or not the 
strength of these relationships is truly significantly greater than that for the relationship between 
RBC-GPx and GPx-1 mRNA levels. It is possible that sampling calves for liver GPx-1 mRNA 
transcript level at only one time point, d 180 of age, 
n_f
Figure 3.11. Regression analysis of relative GPx-1 mRNA n-fold difference and  
erythrocyte GPx-1 activity (Adjusted r
2=0.47; r
2= 0.58).  
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Figure 3.12. Regression analysis of relative GPx-1 mRNA n-fold difference and GPx-3 
activity (Adj r
2= 0.76; r
2= 0.81).  
 
only provided a partial picture of the ongoing relationship between RBC-GPx activity and 
subsequent mRNA levels. We hypothesize that liver biopsy and sampling of blood and plasma to 
obtain samples at consistent intervals may provide a clearer determination of the relationship 
between liver GPx-1 mRNA transcript levels and enzyme activities. 
Conclusions 
The goal of this research was to establish a range of values for RBC-GPx and GPx-3 
activities, as well as for liver Se concentration of neonatal and growing Holstein calves until 
approximately d 180 of age. These specifications are particular to our laboratory based on the 
type of research we wish to perform in the future; thus it was considered pertinent to establish 
reference values for our own use. Secondly, we investigated the effect of Se deficiency on 
  66relative GPx-1 mRNA transcript levels in the 180 d old bovine calf. To our knowledge, there is 
currently no such research in publication.  
The utilization of semi-purified and purified diets for the purpose of inducing Se 
deficiency is often very costly, especially in the feeding of large animals. It may be beneficial in 
the future to determine the minimal length of time required for the feeding of such diets to obtain 
Se deficiency, in order to minimize the amount of time animals must be maintained on such 
diets. The use of RBC-GPx or GPx-3 activity as an indicator of Se status in the growing Holstein 
calf may prove to be a valuable tool; however, determination of serial erythrocyte and plasma Se 
concentrations is necessary to truly establish the GPx activity level at which circulating Se levels 
may be considered deficient. In addition, determination of serial liver Se concentrations may 
prove equally beneficial, as liver Se concentration is generally considered the most accurate 
indicator of Se status.  
The quantification of bovine GPx-1 mRNA in the liver of growing calves may also 
contribute to the current understanding of the effect of Se supplementation and deficiency on 
liver GPx-1 gene expression in the bovine. Considerable research on this subject has been 
performed in rats and, to a lesser extent, pigs, but very little information is available in for cattle. 
Understanding the effects of Se deficiency at the molecular level may provide valuable insight 
into the nature of selenium’s role in health and immunity. However, our research is only a 
starting point; questions remain to be answered regarding the specific biology of Se in the 
ruminant animal. Important comparisons remain to be made between the biology of Se on the 
molecular level in the ruminant animals versus other large animal species. Trials with larger 
sample sizes utilizing serial sampling of liver and other tissues such as the tissues from the 
kidney may be beneficial in furthering our understanding concerning the role of Se in health on a 
molecular level. 
  67There is still considerable information that remains to be learned concerning selenium as 
a micronutrient integral in oxidant status and the proper functioning of the immune system. Basic 
research is required to increase our understanding of antioxidants in immunity and health, both 
on the cellular level and with regards to the body as a whole. 
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  80APPENDIX A: PROTOCOLS 
 
PLASMA AND ERYTHROCYTE COLLECTION PROTOCOL 
Blood Collection 
  1. Collect approximately 10 mL whole blood via jugular veinipuncture in 10 mL  
     vaccutainer tube (BD Vacutainer Systems, Franklin Lakes, NJ) containing sodium  
     heparin to keep blood from clotting. 
2. Mix blood and heparin together by gently inverting tube 3 or 4 times post-draw. 
3. Store collected sample on ice until processing. 
Blood Processing 
  1. Centrifuge vaccutainer tubes for 15 min at 2,000 x g at 4º C. 
  2. After centrifugation, remove plasma layer by pipetting with a disposable pipet and  
     store plasma in a 5 mL Falcon tube (BD Biosciences, San Jose, CA). Avoid removing  
     white buffy layer from the surface of erythrocytes. Store plasma at -80º C until assay.  
3. Remove white buffy layer from surface of erythrocyte layer and discard. 
4. Wash erythrocytes by adding approximately 6 mL of ice cold phosphate buffered  
     saline. Mix by gentle inversion and centrifuge at 2,000 x g at 4º C for 15 min.  
5. Remove resulting supernatant and discard. 
6. Repeat steps 5 and 6 two more times, for a total of three washings. 
7. Following the last wash, pipet approximately 0.5 to 1.0 mL of erythrocytes into a 1.5  
    mL microcentrifuge tube. Freeze erythrocytes at -80º C until assay.  
 
 
 
 
  81GLUTATHIONE PEROXIDASE ACTIVITY ASSAY PROTOCOL 
Pre-Assay Preparation 
  A. Assay Buffer (10x, 50 mM Tris-HCL, pH 7.6, 5 mM EDTA) 
    1. Dilute 2 mL assay buffer concentrate, provided in the Cayman Chemical GPx  
     Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI), with 18  
     mL of HPLC-grade water. 
2. Store diluted buffer at 4º C for no longer than one month. 
  B. Sample Buffer (10x, 50 mM Tris-HCL, pH 7.6, 5mM EDTA, 1 mg/mL BSA) 
    1. Dilute 2 mL of sample buffer concentrate, provided in the Cayman Chemical  
     GPx Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI),  
     with 18 mL of HPLC-grade water. This buffer should be used to dilute the  
     samples prior to assaying. 
    2. Store diluted buffer at 4º C for no longer than one month. 
  C. Dilution of Bovine Glutathione Peroxidase 
    1. Make two 10.5 µL aliquots of Bovine GPx, supplied in the Cayman Chemical  
       GPx Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI), and  
      store in a 0.5 mL microcentrifuge tube at -20º C.  
    2. Immediately prior to use, pipet 10 µL of the Bovine GPx to a 1.5 mL  
         microcentrifuge tube and dilute with 490 µL Sample Buffer. Store on ice until  
         assay. The diluted enzyme is stable for four hours on ice.  
  D. Co-Substrate Mixture (lyophilized NADPH, glutathione, and glutathione reductase) 
    1. Reconstitute each vial by adding 2ml of HPLC-grade water to each vial  
         containing Co-Substrate Mixture and vortex well. The reconstituted agent  
            should be kept at 25ºC while assaying.  
  822. The reconstituted mixture should be stored at 4º C and is stable for 2 days.  
    Reconstituted mixture should not be frozen. 
Sample Preparation 
   Plasma and Erythrocyte Lysate 
    1. Plasma stored at -80 ºC must be thawed on ice prior to assay. No further  
        dilutions are necessary. 
    2. Erythrocytes must be lysed by diluting 1:4 in ice cold HPLC-grade water. 
    3. Dilute erythrocytes 1:400 by adding 2 µL of lysed erythrocytes to 198 µL of ice  
         cold sample buffer. Store dilutions at -80 ºC until assay.   
    4. Thaw frozen erythrocyte 1:400 dilutions on ice for assay. 
Performing the Assay 
  1. Plate Set-up  
     A. Background or non-enzymatic wells: add 120µl of assay buffer and 50µl of co- 
                substrate mixture to three wells. 
B. Positive Control wells (bovine erythrocyte GPx):  add 100µl of assay buffer,     
    50µl of co-substrate mixture, and 20µl of diluted GPx (control) to three wells. 
C. Sample wells: add 100µl of assay buffer, 50µl of co-substrate mixture, and    
    20µl of sample to three wells.  
  2. Allow plate to sit for 5 min to come to room temperature. 
3. Initiate the reactions by adding 20µl of cumene hydroperoxide to all the wells being  
         used. Make sure to note the precise time the reaction is initiated and add the cumene  
         hydroperoxide as quickly as possible. 
4. Carefully shake the plate for a few s to mix. 
5. Incubate plate at 25º C in plate reader. 
  836. Read the absorbance once every min for six at 340nm using a plate reader to obtain  
    7 absorbance reads.  
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Pre-Assay Preparation 
 
  A. Assay Buffer (10x, 50 mM Tris-HCL, pH 7.6, 5 mM EDTA) 
    1. Dilute 2 mL assay buffer concentrate, provided in the Cayman Chemical GPx  
     Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI), with 18  
     mL of HPLC-grade water. 
2. Store diluted buffer at 4º C for no longer than one month. 
  B. Sample Buffer (10x, 50 mM Tris-HCL, pH 7.6, 5mM EDTA, 1 mg/mL BSA) 
    1. Dilute 2 mL of sample buffer concentrate, provided in the Cayman Chemical  
     GPx Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI),  
     with 18 mL of HPLC-grade water. This buffer should be used to dilute the  
     samples prior to assaying. 
    2. Store diluted buffer at 4º C for no longer than one month. 
  C. Dilution of Bovine Glutathione Peroxidase 
    1. Make two 10.5 µL aliquots of Bovine GPx, supplied in the Cayman Chemical  
       GPx Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI), and  
      store in a 0.5 mL microcentrifuge tube at -20º C.  
    2. Immediately prior to use, pipet 10 µL of the Bovine GPx to a 1.5 mL  
         microcentrifuge tube and dilute with 490 µL Sample Buffer. Store on ice until  
         assay. The diluted enzyme is stable for four hours on ice.  
  D. Co-Substrate Mixture (lyophilized NADPH, glutathione, and glutathione reductase) 
    1. Reconstitute each vial by adding 2ml of HPLC-grade water to each vial  
         containing Co-Substrate Mixture and vortex well. The reconstituted agent  
            should be kept at 25ºC while assaying.  
  852. The reconstituted mixture should be stored at 4º C and is stable for 2 days.  
    Reconstituted mixture should not be frozen. 
  E. Double Strength Drabkin’s Reagent (24 mM sodium bicarbonate, 1.6 mM potassium  
      cyanide, 1.2 mM potassium ferricyanide) 
          1. Dissolve all solid reagents in distilled H2O (see Appendix B, Double Strength  
         Drabkin’s Reagent). Store at 25º C. 
  F. 0.01 M Sodium Azide  
      1. Dissolve solid reagents in 100 mL distilled H2O (see Appendix B, 0.01 M  
        Sodium Azide).  
  G. 12 mM Hydrogen Peroxide (see Appendix B, 12 mM Hydrogen Peroxide) 
Sample Preparation 
Tissue Homogenate 
1. Prior to dissection, perfuse tissue with phosphate buffered saline. Snap freeze    
    tissue in liquid nitrogen and store at -80º C until assay. 
2. Grind the tissue into a fine powder using a mortar and pestle under liquid  
    nitrogen. Do not allow tissue to thaw.  
3. Weigh approximately 1 g tissue into a 14 mL Falcon tube ((BD Biosciences,  
    San Jose, CA). Into the tube add 10mL cold buffer (50 mM Tris-HCL, pH 7.5,  
    5 mM EDTA, and 1 mM DTT) per gram of tissue. 
4. Centrifuge at 10,000 x g for 15 min at 4ºC.  
5. Remove the supernatant for assay and pipet into another 14 mL Falcon tube   
(BD Biosciences, San Jose, CA). Make one 1.5 mL aliquot and freeze both at 
-80ºC. The sample will be stable for at least 1 month. 
 
  86Performing the Assay 
  1. Plate Set-Up 
A. Background or non-enzymatic wells: add 90µl of assay buffer, 50µl of co- 
substrate mixture, 20µl of Drabkin’s Reagent, and 10µl sodium azide to each of     
three wells. 
B. Positive Control wells (bovine erythrocyte GPx):  add 70µl of assay buffer,  
    50µl of co-substrate mixture, 20µl of Drabkin’s reagent, 10µl of sodium azide,  
    and 20µl of diluted GPx (control) to three wells. 
C. Sample wells: add 70µl of assay buffer, 50µl of co-substrate mixture, 20µl of  
           Drabkin’s reagent, 10µl of sodium azide, and 20µl of sample to three wells.  
2. Initiate the reactions by adding 20µl of 12 mM hydrogen peroxide to all the  
        wells being used. Make sure to note the precise time the reaction is initiated  
    and add the hydrogen peroxide as quickly as possible. 
3.Allow plate to sit for 5 min to come to room temperature 
4. Carefully shake the plate for a few s to mix. 
5. Incubate the plate at 25º C in the plate reader for the duration of the assay. 
6. Read the absorbance once every min at 340nm using a plate reader to obtain  
    at least 5 time points.  
 
 
   
 
 
 
 
  87CALCULATION OF GLUTATHIONE PEROXIDASE ACTIVITY ASSAY RESULTS 
1. Determine the change in absorbance (ΔA340) per min by: 
  a. Plotting the absorbance values as a function to obtain the slope (rate) of the  
          linear portion of the curve –or-  
b. Select two points on the linear portion of the curve and determine the change in  
      absorbance during that time using the following equation: 
ΔA340/min = A340 (Time 2) – A340 (Time 1)/ Time 2 (min) – Time 1 (min) 
2. Determine the rate of ΔA340/min for the background or non-enzymatic wells and  
    subtract this rate from that of the sample wells.  
3. Use the following formula to calculate the GPx activity. The reaction rate at 340nm   
    can be determined using the NADPH extinction coefficient of 0.00373 µM
-1. One  
    unit is defined as the amount of enzyme that will cause the oxidation of 1.0 nmol of  
    NADPH to NADP per min at 25ºC. 
GPx activity = [(ΔA340/min)/0.00373µM
-1] x (0.19ml/0.02ml) x sample dilution = nmol/min/ml 
 
 
 
 
 
 
 
 
 
 
  88BRADFORD PROTEIN ASSAY PROTCOL 
Preparation of Standard Curve with 2 mg/mL BSA 
1. Prepare standards in 1.5µL microcentrifuge tubes. Prepare standard dilutions using 2    
    mg/mL BSA (Bio-Rad Laboratories, Inc., Hercules, CA) according to table A.1.: 
 
Table A.1. Standard curve dilution preparation with 2 mg/mL BSA. 
 
       Tube # 
Standard 
volume (µL) 
Source of 
Standard 
Diluent 
Volume (µL) 
Final 
[Protein], 
ng/mL
1 70  2  mg/mL  stock  0  2,000
2  75 2  mg/mL  stock 25  1,500
3  70 2  mg/mL  stock 70  1,000
4  35 Tube  2 35  750
5  70 Tube  3 70  500
6  70 Tube  5 70  250
7  70 Tube  6 70  125
8 (blank)  ---  ---  70  0
 
2. Pipette 20 µL from each microcentrifuge tube into each of three clean, dry cuvettes (curve   
    is constructed in triplicate). 
3. Add 1mL Coomassie Blue dye (Bio-Rad Laboratories, Inc., Hercules, CA) to each cuvette. 
4. Allow cuvettes to incubate for at least 5 min. Samples should not be incubated for  
    longer than 1 hour at room temperature. 
5. Use blank to zero the spectrophotometer. Select standard curve set-up procedure on the  
    spectrophotometer. Enter # of standards, # or replicates per standard (3), and enter  
    standard concentrations when prompted.  
6. Print out results and save in spectrophotometer. 
Standard 1 mL Assay with Coomassie Brilliant Blue G-250 
1. Remove 1x Coomassie Brilliant Blue (Bio-Rad Laboratories, Inc., Hercules, CA ) dye   
  89    reagent from 4ºC storage and allow it to warm to ambient temperature. Invert the 1x   
   dye reagent a few times before use. 
  2. Prepare sample dilutions in glass-filtered water. Plasma samples require 1:50 dilution.  
      Liver tissue hemolysate samples require 1:10 dilution. 
3. Pipet 20 µL of each unknown sample solution into separate clean cuvettes. Add 1 mL    
of 1x Coomassie Blue dye (Bio-Rad Laboratories, Inc., Hercules, CA) to each cuvette 
and invert.  
4. Incubate at room temperature for at least 5 min. Samples should not be incubated  
         longer than 1 hour at room temperature.  
5. The absorbance wavelength is 595nm. Before analyzing samples, zero the  
         spectrophotometer with the blank sample. Blank sample consists of 20µL glass-filtered  
     water and 1 mL Coomassie Brilliant Blue dye (Bio-Rad Laboratories, Inc., Hercules,  
     CA).  
6. Measure the absorbance of the unknown samples, using the pre-saved standard curve  
         made prior to running the samples for comparison calculations. 
 
 
 
 
 
     .  
 
 
 
 
  90QUANTICHROM
TM HEMOGLOBIN ASSAY KIT PROTOCOL 
1. 96-Well plate set-up 
A. Blank and standard wells. 
Pipette 50 μl water (for blank) and 50 μl standard (for standard) into wells of a 
clear bottom 96-well plate. Transfer 200 μl water into the blank and standard 
wells. 
B. Sample wells. 
Blood samples should be diluted 100-fold in distilled water (n=100). 
Transfer 50 μl samples into wells in triplicate per sample. Avoid bubble formation 
during the pipetting steps. 
2. Add 200 μl Reagent to sample wells and tap plate lightly to mix. 
3. Incubate 5 min at room temperature. Read OD at 400 nm. Signal is  
    stable for at least 2 hours.  
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Pre-isolation Set-up 
1.  Bring all buffers except Tris-HCl to room-temperature prior to use. 
2.  Resuspend Dynabeads Oligo(dT)25 (Dynal Biotech, Inc., Lake Success, NY, USA) 
fully before use by gentle pipetting. 
4. Pre-heat a water bath to 75°C. 
5. Prepare individual aliquots of all buffers and reagents required for reaction prior to  
    RNA isolation procedure.  
6. Prepare Dynabeads Oligo(dT)25 (Dynal Biotech, Inc., Lake Success, NY, USA) for  
    isolation procedure. 
a. Transfer 250µl of beads from the stock tube to a RNase-free 1.5ml     
    microcentrifuge tube and place the tube on a magnet. 
b. After 30 s (or when the suspension is clear) remove the supernatant. 
c. Remove the vial from the magnet and wash the beads by resuspending in 250µl  
    of fresh Lysis/Binding buffer (100 mM Tris-HCl, pH 8.0, 500 mM LiCl, 10  
    mM EDTA, 1% lithium dodecylsulfate, 5 mM dithiothreitol).  
d. When the sample lysate is ready for combination with the beads, place the tube  
    on the magnet and remove the lysis/binding buffer after 30 s (or when  
    the suspension is clear). 
Preparation of Lysate from Liver Tissue 
1.  Weigh and handle the animal tissue while frozen to avoid RNA degradation. Do not 
exceed the specified amount of tissue, as using too much tissue will reduce the 
mRNA yield and purity. 
2.  Treat clean, autoclaved mortar and pestle with RNase-Zap to remove trace RNases.  
  923.  Freeze the microcentrifuge tube into which the ground tissue will be placed by 
placing it in dry ice. Weigh the frozen microcentrifuge tube, using it to zero the scale, 
and replace the tube in dry ice. 
4.  Pre-freeze the mortar and pestle in liquid nitrogen prior to adding tissue. Grind frozen 
tissue in liquid nitrogen. Work quickly. 
5.  Transfer the frozen powder to the microcentrifuge tube. Quickly add 1250µL 
Lysis/Binding Buffer to tube/sample and homogenize for 1 to 2 min until complete 
lysis is obtained. Rapid lysis in the Lysis/Binding Buffer is critical for obtaining 
undegraded mRNA. 
6.  Shear the DNA by forcing the lysate 3-5 times through a 21 gauge needle using a 1-
2ml syringe. Use force. 
7.  Centrifuge the lysate for 30-60 s at approximately 10,000 x g to remove debris and 
reduce foaming after shearing.  
8.  Transfer the lysate to the tube containing the prepared Dynabeads. 
RNA Isolation Procedure 
1.  Mix the beads with the sample lysate and incubate with continuous mixing on roller 
mixer for 3-5 min at room temperature to allow the Poly-A tail of the mRNA to 
anneal to the oligo-dT on the beads.  
2.  Place the vial on the magnet for 2 min and remove the supernatant. Place supernatant 
into a clean RNase-free 1.5ml microcentrifuge tube and place on ice.  
3.  Wash the beads/mRNA complex two times with 2ml of Washing Buffer A ( 10 mM 
Tris-HCl, pH 8.0, 150 mM LiCl, 1mM EDTA, 0.1% lithium dodecylsulfate) at room 
temperature. Use the magnet to separate the beads from the solution between each 
washing step, removing the tube from the rack prior to adding washing buffer each 
  93time. Fully resuspend the Dynabead/mRNA complex at each washing by short, gentle 
vortexing or pipetting 
4.  Wash the beads/mRNA complex once with 1-1.5ml Washing Buffer B (10 mM Tris-
HCl, pH 8.0, 150 mM LiCl, 1 mM EDTA) at room temperature. Be sure to fully 
resuspend the beads in the washing buffer by gently vortexing or pipetting. Use the 
magnet to separate the beads from the solution.  
5.  To elute the beads, add 25µl 10mM Tris-HCl (Elution Buffer), ensuring that the 
beads are completely resuspended in solution by gentle pipetting, and incubate at 65-
80°C for 2 min. Place the tube immediately on the magnet and transfer the 
supernatant containing the mRNA to a new RNase-free tube. Place the mRNA 
immediately on ice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  94cDNA SYNTHESIS PROTOCOL 
1. Mix 4 µL of iScript reaction mix, 1 µL of reverse transcriptase, and 5 µL of autoclaved water. 
2. Make master mixes when possible. 
3. Add 10 µL of mRNA sample. 
4. Extra mix should be prepared for the no mRNA template negative control.  
5. Total volume mix should be 20 µL.  
6. Place the mix in the thermocycler. 
7. Run the thermocycler at 25ºC for 5 min, 42 ºC for 30 min, denaturation at 85 ºC for 5  
    min, and a final hold at 4 ºC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  95REVERSE TRANSCRIPTASE PCR PROTOCOL 
1. Mix 5 µL of 10X PCR buffer, 1 µL dNTP mix (Appendix B), 2 µL Jump Start 
TM  REDTaq 
TM  
    DNA Polymerase (Sigma-Aldrich, Inc., St. Louis, MO, USA) and 39 µL water. Add 1 µL of each 20  
    ρmol primer. Make a larger volume for multiple samples when appropriate (Master Mix;  
    Appendix B, rtMM). 
2. Add 1 µL of the cDNA sample to each of the master mixes containing the 20 ρmol primers.  
3. Prepare enough of each master mix, both the mix without the 20 ρmol primers and the mix  
    with the primers added, for the negative control, into which no cDNA will be added.  
4. Place the sample into the thermocycler.  
5. Run one cycle of 1 min at 95ºC; 35 cycles of PCR (95 ºC for 30 s, 56 ºC for 30  
    s, and 72 ºC for 30 s); followed by 72 ºC for 4 min with a final hold  
    temperature of 4 ºC.  
 
 
 
 
 
 
 
 
 
 
 
 
  96QUANTITATIVE PCR PROTOCOL 
1. Mix 12.5 µL of iQ SYBR 
TM Green 2X Supermix (Bio-Rad Laboratories, Inc., Hercules, CA,  
    USA), 1 µL of 20 ρmol Primer 1, 1 of 20 ρmol µL of Primer 2, and 9.5 µL autoclaved water  
    for each well.  
2. A master mix should be formulated for each gene of interest (Master Mix; Appendix B,  
    bGPxMM or PaMM). 
3. Prepare enough master mix to run both the calibrator and negative controls containing no  
    cDNA for each gene of interest. 
4. Pipette 96 µL of bGPxMM into one 0.5 mL microcentrifuge tube for each sample  
    (calf)/calibrator/NT control.  
5. Add 4 µL cDNA/calibrator/H2O for NT control to the corresponding microcentrifuge tube  
    containing 96 µL bGPxMM. 
6. Pipette 96 µL of PaMM into one 0.5 mL microcentrifuge tube for each sample  
    (calf)/calibrator/H2O for NT control.  
7. Add 4 µL cDNA/calibrator/H2O for NT control to the corresponding microcentrifuge tube  
    containing 96 µL PaMM. 
8. Pipette 25 µL from each sample for each gene of interest into each of three wells.   
9. Place the 96-well plate into the thermocycler.  
10. Run one cycle of 3 min at 95ºC; 40 cycles of PCR (95 ºC for 10 s and 56 ºC for 45  
    s); a melting curve consisting of 95 ºC for 1 min followed by 55 ºC for 1 min, a  
    step cycle with 0 repeats starting at 55 ºC for 10 s with a +0.5 ºC/s transition rate;  
    and a final hold at 4 ºC. 
 
 
  97GENE EXPRESSION QUANTIFICATION PROTOCOL 
1. Use the method described by Pfaffl (2001). 
2. Use the combined cDNA from the baseline calves (Materials and Methods) as the calibrator  
    for the target genes. The same calibrator should be used throughout all the experiments and  
    plates. 
3. Use Poly-A polymerase as the endogenous control gene. 
4. Obtain efficiencies by performing a 10-fold dilution standard curve on all genes of interest,  
    both the reference and target genes, prior to analysis.  
5. Use the signal of the reference gene Poly-A to normalize the target gene signals of each  
    sample by subtracting the average CT value of Poly-A from that of the target gene. 
6. Calibrate the ΔCT for gene transcription against the sample used as the calibrator. Calculate  
    both a ΔCTT for the target gene and a ΔCTR for the reference gene. 
a. Calculate the ΔCTT by subtracting the CT value for the target gene in the calibrator  
    from the CT value for the target gene in each sample.  
b. Calculate the ΔCTR by subtracting the CT value for the reference gene in the calibrator  
    from that of the reference gene in each sample. 
7. Calculate the relative linear amount of target molecules relative to the calibrator by using the  
    following equation: 
n-fold difference = Efficiency Target Gene
ΔCTT / Efficiency Reference Gene
ΔCTR 
  98APPENDIX B: BUFFER AND STOCK PREPARATIONS 
PHOSPHATE BUFFERED SALINE 
a 
Component Product  No. Company Amount
Sodium Chloride  S271-500  Fischer Scientific 80.0 g
PX1405-CB607 
Matheson 
Coleman and 
Bell 
2.0 g Potassium Chloride 
Sodium Phosphate  7917-1  Mallinckrodt  11.5 g
Potassium 
Phosphate  P0662-500G Sigma  2.0  g
ddH2O -  -  1000  mL
               a 10X concentrate. Store at 4ºC. Dilute to 1:10 in ddH2O for use in washing cells and        
             perfusing tissue. 
 
 
TISSUE HOMOGENATION BUFFER 
a 
 
Component  Product No.  Company  Final mM mL, mg / 250 mL
1 M Tris-HCl, pH 7.5  15567-027  Invitrogen  50 12.5
EDTA JT8993-1  JT  Baker  5 465.3
Dithiothreitol D-1532  Invitrogen  1 38.5
- -  - 237.5 ddH2O 
a DTT has short half-life. Use immediately; do not store! 
 
 
DOUBLE STRENGTH DRABKIN’S REAGENT 
 
Product No.  Company  Final mM  mL, mg / 100 
mL Component 
Sodium 
Bicarbonate  S6014-25G Sigma-Aldrich  24  200
Potassium 
Cyanide  60178-25G Sigma  Aldrich  1.6  10.4
Potassium 
Ferricyanide  244023-5G Sigma-Aldrich  1.2  39.6
- -  -  100 dd H2O 
 
 
 
 
  990.01 M SODIUM AZIDE SOLUTION 
 
Component Product  No.  Company  mL, mg / 100 mL 
Sodium Azide  S8032-25G  Sigma-Aldrich  65
- -  100 ddH2O 
 
 
12 mM HYDROGEN PEROXIDE
a,b 
 
Component  Product No.  Company  mL/100 mL
30% H2O2, w/w  216763-100ml  Sigma-Aldrich  0.124
- -  99.876 ddH2O 
a Store capped in dark vial at 4º C. 
b Decant small amount into separate vial for each assay. 
 
 
iSCRIPT REVERSE TRANSCRIPTASE cDNA SYNTHESIS MIX 
 
Component Product  No.  Company  Amount
iScript Reaction Mix  170-8891  BioRad  4 µL
Reverse Transcriptase  170-8891  BioRad  1 µL 
- -  10 µL mRNA 
Autoclaved H2O -  -  5  µL
 
 
dNTP MIX 
a 
Component Product  No.  Company  Amount
dATP 1-969-064  Roche  10  µL
dCTP 1-969-064  Roche  10 µL
dGTP 1-969-064  Roche  10 µL
dTTP 1-969-064  Roche  10 µL
- -  60 µL Autoclaved H2O 
a Store at -20ºC for 2 to 3 months 
  100REVERSE TRANSCRIPTION PCR MASTER MIX (rtMM) 
Component Product  No.  Company  Amount 
(Per Sample)
- -  39 µL Autoclaved H2O 
10X PCR Buffer  D-8187  Sigma  5 µL 
- -  1 µL dNTP Mix 
-  Invitrogen 1  µL Primer 1 
-  Invitrogen 1  µL Primer 2 
Jump Start Taq Polymerase  D-8187  Sigma  2 µL
 
REVERSE TRANSCRIPTION PCR MIX 
Component Product  No. Company  Amount 
(Per Sample) 
- -  49 µL  rtMM 
- -  1 µL  cDNA 
 
QUANTITATIVE PCR REACTION MIX FOR bGPx 
Component  Product No.  Company  Amount (Per Well)
SYBR Green 2X Supermix  170-8882  BioRad  12.5 µL
-  Invitrogen 1  µL bGPx Primer 1 
-  Invitrogen 1  µL bGPx Primer 2 
- -  9.5 µL Autoclaved H2O 
 
QUANTITATIVE PCR REACTION MIX FOR POLY-A 
Component Product  No.  Company  Amount 
(Per Well)
SYBR Green 2X Reaction Mix  170-8882  BioRad  12.5 µL
-  Invitrogen  1 µL Poly-A Primer 1 
-  Invitrogen 1  µL Poly-A Primer 2 
Autoclaved H2O  - - 9.5 µL
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QUANTITATIVE PCR MASTER MIX FOR bGPx (bGPxMM) 
 
Component Product  No.  Company  Amount 
(Per Gene)
a
SYBR Green 2X Reaction Mix  170-8882  BioRad  512.5 µL
-  Invitrogen 41  µL bGPx Primer 1 
-  Invitrogen 41  µL bGPx Primer 2 
- -  389.5 µL Autoclaved H2O 
      
a Analyzing 41 reactions (3 wells per calf/calibrator/NT + 1 per calf/calibrator/NT) 
       Note: Add an additional reaction to each calf/calibrator/NT to ensure enough in case  
                            of pipetting error. 
 
 
QUANTITATIVE PCR MASTER MIX FOR POLY-A (PaMM) 
 
Component Product  No.  Company  Amount 
(Per Gene)
a
SYBR Green 2X Reaction Mix  170-8882  BioRad  512.5 µL
-  Invitrogen 41  µL Poly-A Primer 1 
-  Invitrogen 41  µL Poly-A Primer 2 
- -  389.5 µL Autoclaved H2O 
                
a Analyzing 41 reactions (3 wells per calf/calibrator/NT + 1 per calf/calibrator/NT) 
       Note: Add an additional reaction to each calf/calibrator/NT to ensure enough in case  
                            of pipetting error. 
 
 
 
 
 
QUANTITATIVE PCR MASTER MIX FOR EACH SAMPLE/CALIBRATOR/NT 
(MMsamp) 
 
Component Product  No.  Company  Amount 
(Per Sample)
- -  96 µL  bGPxMM or PaMM 
cDNA
a/calibrator/H2O for NT control  - -  4 µL
 
a 1:10 dilution of cDNA was used for all samples and calibrator. 
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